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ABSTRACT 
The developing brain is vulnerable to external insults, and perinatal brain 
injury (PBI) is a major cause of life-long neurological syndromes such as 
cerebral palsy. Currently, no pharmaceutical intervention is available. Hy-
poxia/ischemia (HI), infections and inflammation are implicated in the path-
ogenesis of PBI. However, the crosstalk between these etiologies is not fully 
understood. Toll-like receptors (TLR) 3 and TLR2 are responsible for sens-
ing viral and bacterial infections and initiating the inflammatory response. 
The aim of this thesis was to investigate the effect of systemic inflammation 
induced by activation of these TLRs on neonatal HI brain injury. We demon-
strate that intraperitoneal administration of TLR3 and TLR2 ligands 
(PolyI:C and P3C, respectively) prior to HI increases the brain injury in ne-
onatal  mice. PolyI:C and P3C induced neuroinflammation and altered mi-
croglial phenotype as assessed by RT-qPCR, multiplex cytokine assay or 
flow cytometry. PolyI:C also upregulated the pro-apoptotic gene, Fasl, ex-
pression and reduced activation of pro-survival signaling molecule Akt. On 
the other hand, P3C suppressed mitochondrial respiration, a major mecha-
nism of cellular energy production. P3C, unlike other TLR agonists, induced 
marked infiltration of leukocytes to the cerebral spinal fluid and brain of 
neonatal mice and rats. Confocal microscopy, Cre recombinase-mediated 
gene targeting and in vitro cell transmigration assay revealed the choroid 
plexus as a site of leukocyte entry. RNA sequencing of the choroid plexus 
followed by transcriptome cluster analysis and Ingenuity Pathway Analysis 
revealed potential mechanisms of leukocyte infiltration, including a specific 
chemotaxis signature and cytoskeleton-related pathways. Finally, we show 
that N-acetylcysteine treatment inhibits TLR2-mediated leukocyte traffick-
ing in vivo and in vitro. 
To conclude, this thesis describe a TLR-mediated link between systemic 
inflammation and developing brain with detrimental consequences on HI 
brain injury, suggesting potential novel therapeutic strategies. 
Keywords: neonatal brain injury, hypoxia-ischemia, inflammation, infec-
tion, Toll-like receptor, choroid plexus 
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 Sammanfattning på svenska 
Hjärnskador hos nyfödda barn är den vanligaste orsaken till neurologiska 
problem (såsom cerebral pares) bland barn. I Sverige diagnostiseras 2 av 
1000 spädbarn med cerebral pares. Dessa hjärnskador uppstår i både 
fullgångna och för tidigt födda barn, men förekomsten är betydligt högre 
bland barn som fötts förtidigt. En vanlig orsak till hjärnskadorna hos 
spädbarn är brist på syre (hypoxi) och/eller lågt blodflöde (ischemi) till 
hjärnan. Ännu en riskfaktor är infektioner hos spädbarnet eller mamman 
någon gång runt födseln. Hur infektioner kan öka risken för hjärnskada i 
nyfödda var den huvudsakliga frågan vi ville försöka svara på i denna avhan-
dling. Infektioner känns igen av vårt immunförsvar genom specifika recep-
torer som kallas Toll-liknande receptor (TLR) som finns på ytan av alla 
immunceller. Virus aktiverar framförallt TLR3 och en viss grupp bakterier 
aktiverar TLR2, och genom aktivering av dessa receptorer startar en immu-
nologisk reaktion i kroppen. 
 
Vi använder oss av en modell av hypoxi/ischemi (HI) hos nyfödda möss som 
producerar hjärnskador som liknar dem som kan ses hos spädbarn. Genom 
att administrera specifika ämnen aktiverades TLR3 och TLR2 innan HI. Vi 
upptäckte att aktivering av dessa receptorer ökar hjärnskadorna i både grå 
substans (nervceller) och vit substans (nervfibrer). Det visar på att virus- och 
bakterieinfektioner gör hjärnan känsligare för HI. Vi undrade sedan vad det 
är som orsakar denna ökade känslighet. Vi upptäckte att aktivering av TLR3 
leder till en kraftig inflammatorisk respons i hjärnan, vilket ledde till specif-
ika cellförändringar som pekade på minskad överlevnadsfunktion samt att 
hjärnans egna immunceller (s.k. mikroglia) blev mer reaktiva. Aktiveringen 
av TLR2 ledde till invasion av vita blodkroppar till hjärnan från blodet och 
minskad mitokondriefunktion (mitokondrierna ger celler energi) i hjärnans 
celler. Vi såg att de vita blodkropparna tar sig in i hjärnan via ett litet organ 
i hjärnan som kallas plexus choroidea. Därför analyserade vi genförän-
dringar i plexus choroidea efter TLR2-stimulering och kunde fastställa de 
molekylära mekanismer som kan göra det möjligt för vita blodkroppar att ta 
sig in i hjärnan. Slutligen visade vi att behandling av neonatala råttor med 
N-acetylcystein, ett antioxidantläkemedel, blockerar invasionen av vita 
blodkroppar till hjärnan i denna modell. Sammanfattningsvis fann vi att vi-
rus- och bakterieinfektioner orsakar inflammation i hjärnan och gör hjärnan 
känsligare för HI-relaterade hjärnskador. Minskning av inflammationen i 
hjärnan genom riktade behandlingar mot plexus choroidea eller genom 
behandling med N-acetylcystein kan minska risken för hjärnskador hos 
nyfödda. 
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Introduction 
Brain development 
The brain is the most complex organ in the body; hence, its development consist 
of intricate processes including formation, differentiation, migration and connec-
tion of neurons. The cerebral cortex grey matter that constitutes more than 80% of 
the adult human brain mass contains 19% of the total brain neurons (16 billion), 
while cerebellum that has 10% of brain mass contains 80% of all neurons (69 
billion). Almost half of  the brain cells are non-neuronal, cells which are mainly 
located in white matter (15 billion) and a small proportion in grey matter (1.5 bil-
lion) (Azevedo et al., 2009). In humans, brain development starts as early as week 
3 of gestation (GW3) when the neural plate emerge from neuroepithelial cells of 
the ectoderm (Stiles and Jernigan, 2010). This is followed by formation and clo-
sure of the neural tube that is the scaffold structure for development of the central 
nervous system (CNS). The neural tube is also eventually transformed into the 
ventricular system of the brain. 
Progenitor cells, such as radial glial cells, line the internal side of the neural tube 
and start dividing and giving rise to pyramidal neural cells by GW5 (Budday et 
al., 2015). The human brain developmental time course from GW5 onwards is 
depicted in figure 1. The newborn neurons migrate radially from the subventricu-
lar zone (SVZ) outward to form the cortical plate (Budday et al., 2015). Differen-
tiation of the migrated neurons give rise to two main inhibitory and excitatory 
neuronal types and several subtypes, of which sixteen has been identified by sin-
gle-cell nucleus RNA sequencing (Lake et al., 2016). All six layers of cortex are 
shaped by GW18, and thereafter, dendritic and axonal growth and synaptogenesis 
begins (Budday et al., 2015). These processes are guided by intrinsic and extrinsic 
cues, and local mRNA translation plays a key role (Holt and Schuman, 2013). The 
migration of neurons continues postnatally in humans until 1.5-2 years of age 
(Sanai et al., 2011; Paredes et al., 2016). A large population of neurons migrate 
from SVZ to the frontal lobe during the first 5 months of human life and differen-
tiate into inhibitory neurons (Paredes et al., 2016). Synaptogenesis is followed 
postnatally by elimination of unnecessary synapses by microglia and astrocytes in 
a process mediated by components from the complement system, MEGF10 (mul-
tiple epidermal growth factor-like domains protein 10) and MERTK (mer tyrosine 
kinase) phagocytic pathways (Stevens et al., 2007; Chung et al., 2013). Synaptic 
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pruning is a critical mechanism of sculpting neural circuit and brain plasticity 
(Riccomagno and Kolodkin, 2015). Astrocytes emerge from either radial glial 
cells prenatally or progenitor cells in SVZ postnatally (Ge et al., 2012).   They are 
detected in the human brain by GW15 (Roessmann and Gambetti, 1986). Micro-
glia, the professional immune cells of the brain, originate from yolk sac primitive 
macrophages and migrate to the developing brain as early as GW5 (Monier et al., 
2007; Ginhoux et al., 2010).  Therefore, both microglia and astrocytes are instru-
mental in shaping the developing brain from early stages (Reemst et al., 2016). 
The progenitors of oligodendrocytes (OL), the myelinating cells, are generated in 
the fetal brain around GW17 and continue to proliferate and differentiate into ma-
ture OL until early childhood (Rakic and Zecevic, 2003; Yeung et al., 2014). My-
elination, therefore, begins after OL appear in the brain around mid-gestation 
(Tosic et al., 2002; Yeung et al., 2014). Myelination in adult brain occurs as one 
of the mechanisms of brain plasticity induced by neural activity (Liu et al., 2012). 
Brain vasculature starts to form from GW5 (Budday et al., 2015) and choroid 
plexus from GW7 (Dziegielewska et al., 2001)  and both contain the barrier struc-
tures that separates the CNS from the periphery. 
Brain interfaces 
Brain vasculature, choroid plexus and circumventricular organs (CVOs) constitute 
Figure 1. The time course of events in developing brain of human and potential perinatal 
challenges. EL=elimination 
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the major brain interfaces. The CNS is protected from unwanted compounds, in-
cluding immune system components, by the blood-brain barrier (BBB) in the brain 
vasculature and blood-cerebrospinal fluid barrier (BCSFB) in the choroid plexus 
as well as barrier structures surrounding CVOs. Essential compounds such as nu-
trients and ions pass these barriers into the CNS by, for example, passive diffusion, 
energy-dependent active transport and energy-independent facilitated diffusion 
(Banks, 2016). In addition, some large molecules such as albumin has been shown 
to access the CNS in small amounts through extracellular pathways (functional 
leaks) such as via vessels of the pial surface of the meninges and some CVOs (e.g. 
median eminence) (Banks, 2016).  
Brain microvasculature comprises of pial arteries in the subarachnoid space, arte-
rioles in the Virchow-Robin space, penetrating arterioles and capillaries.  All these 
structures are equipped with BBB; however, capillaries lack the smooth muscle 
layer (Kulik et al., 2008). BBB consists of various junction proteins between the 
endothelial cells of brain vasculature, while similar structures are present between 
epithelial cells of the choroid plexus that constitutes the BCSFB (Redzic, 2011a). 
The structure includes adherence junctions, tight junctions, and gap junctions. 
These can be transmembrane proteins or cytoplasmic plaque proteins that interact 
with cell scaffolds to form the functional barrier (Redzic, 2011b). Claudins are a 
family of transmembrane proteins that are believed to have a central role in the 
function of tight junctions. It is known that claudin 3, 5 and 12 dominate in the  
Figure 2. Left panel: two-photon image of a P9 mouse choroid plexus immunolabeled for 
tight junction protein occludin (red) of epithelial cells and CD31 (green) of vessels. Right 
panel: transmission electron microscopy image of the lateral ventricle choroid plexus of a 
P9 mouse. 
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BBB, while claudin 1, 2, 3 and 11 dominate in the choroid plexus epithelium bar-
rier (Redzic, 2011b). BBB is supported and regulated by astrocyte end-feet and 
pericytes, which together with neurons, constitute the neurovascular unit (Haw-
kins and Davis, 2005; Armulik et al., 2010). Both BBB and BCSFB are formed 
and become functional early during development in humans, non-human primates 
and rodents (Saunders et al., 2012; Ek et al., 2015). In humans, BBB tight junction 
proteins occludin and claudin-5 were detected in the fetal brain at GW 16 (Ballabh 
et al., 2005). Moreover, peripherally injected dye (trypan blue) in aborted human 
fetuses (from ~GW12) did not diffuse into the CNS, supporting a functional BBB 
early in development (Grontoft, 1954; Saunders et al., 2012). The choroid plex-
uses are located in the brain ventricles and their development in humans starts as 
early as GW7 (Fig. 1). It consists of fenestrated vessels surrounded by a monolayer 
of epithelial cells (CPECs)(Mortazavi et al., 2013). The tight junction structure 
between the CPECs constitutes the BCSFB (Fig. 2). The stroma between CPEC 
and blood vessels contain some resident macrophages and dendritic cells (Quin-
tana et al., 2015). The apical side (CSF side) of the choroid plexus is villous, which 
increases the choroid plexus surface area, and consequently, increases CSF pro-
duction.(Lun et al., 2015). Special macrophages called Kolmer’s epiplexus cells 
crawl on the microvilli (Fig. 2). Tufts of primary or motile cilia are also present 
on the apical side (Fig. 2) with roles in CSF circulation and osmo-/chemosensation 
(Wolburg and Paulus, 2010; Lun et al., 2015). The principal function of the cho-
roid plexus is to produce of CSF. In addition to water and ions, CSF contains many 
proteins (e.g. neurotropic factors), metabolites, hormones and microRNAs, of 
which many are transported from peripheral blood and some are produced by the 
choroid plexus itself (Lehtinen et al., 2011; Lun et al., 2015). Therefore, the cho-
roid plexus has a pivotal role in the CNS development and physiological functions. 
As an essential gatekeeper to the brain, the malfunction of the choroid plexus can-
contribute to several CNS pathologies, including some neurodegenerative diseases 
(Balusu et al., 2016a). 
Brain immune cells 
Under normal physiological conditions, microglia cells are the sole professional 
immune cells in the brain parenchyma, playing important roles in brain develop-
ment and maintenance. For some decades, it was assumed that microglia are 
dormant cells that become active only when there is an infection or injury. How-
ever, a substantial interest in microglia biology in the last decade has shed light 
on many functions of microglia in the normal brain. Synaptic pruning and remod-
eling during development and phagocytosis of apoptotic neurons without inflam-
mation are among emerging functions attributed to microglia under physiological 
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conditions (Takahashi et al., 2005; Paolicelli et al., 2011; Schafer et al., 2012). 
Microglia originate from a subset of precursor monocytes in the yolk sac during 
early stages of embryo development (Ginhoux et al., 2010; Kierdorf et al., 2013). 
Recently, it was discovered that microglia cells express regional diversity in the 
healthy brain (Grabert et al., 2016). Other resident macrophages are also present 
in the meninges, choroid plexus  and perivascular spaces. Meningeal and peri-
vascular macrophages originate from embryonic hematopoietic precursors, and 
similar to microglia, have a long life span. However, choroid plexus macrophages, 
although having the same origin, are short-lived and replenished by blood mono-
cytes after birth (Goldmann et al., 2016). Furthermore, a small number of T cells, 
mostly effector-memory T cells from adaptive immunity, are present in the CSF 
surveying the CNS for potential antigens (Engelhardt and Ransohoff, 2012). Re-
cently, it was discovered that the brain is connected to the lymphatic system, chal-
lenging the long-held dogma that the brain is an “immune-privileged” organ 
(Louveau et al., 2015). However, the fact that immune homeostasis of the brain is 
strictly controlled remains unswerving. 
Perinatal brain injury 
As depicted in figure 1, the perinatal period, is a critical time for brain develop-
ment and is vulnerable to external challenges. Injury to the perinatal brain can 
occur in 4 clinical settings: neonatal encephalopathy (NE) of term infants, perina-
tal stroke, preterm brain injury and systemic infections (Hagberg et al., 2015; Hag-
berg et al., 2016). NE occurs in 3/1000 live births and is attributed mainly to 
hypoxia and/or ischemia (HI), although this has been recently questioned (Badawi 
et al., 1998; McIntyre et al., 2015). Therefore, it has been suggested that the term 
“hypoxic/ischemic encephalopathy” (HIE) should be used only when criteria for 
intrapartum asphyxia, such as marked acidosis, is present (Volpe, 2012).  
The clinical symptoms such as seizures, feeding difficulties, irritability and altered 
tonus, together with an altered electroencephalogram pattern, is associated with 
HIE in term infants (Pierrat et al., 2005; Kurinczuk et al., 2010; Stridh et al., 2011). 
Neonates that develop HIE more often present with low APGAR score, and um-
bilical cord acidosis at birth (Allen and Brandon, 2011). Insufficient supply of 
oxygen (hypoxia) and/or blood (ischemia) to the fetus/newborn can be due to an-
tepartum, intrapartum and postpartum complications such as maternal hypoten-
sion, uterine rupture, cord prolapse, placental abruption or systemic inflammation. 
Moderate hypothermia (33.5ºC) started within 6 hour of birth and continued for 3 
days is currently the only available treatment of HIE. Hypothermia significantly 
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increases the survival rate and improves the disability outcome, although not all 
infants benefit from this treatment (Edwards et al., 2010; Shankaran et al., 2012). 
The pattern of brain injury differs between term and preterm infants. In preterm 
infants, the injury appears most commonly in the form of white matter damage 
(e.g. if severe, periventricular leukomalacia; PVL) and intraventricular hemor-
rhage (IVH). In the term infants, focal grey matter injury in basal ganglia, thala-
mus, and cortex is most common (Mallard and Vexler, 2015b).  
Perinatal stroke has two subtypes, perinatal arterial ischemic stroke and cerebral 
sinovenous thrombosis, with occurrence rate of 1/1600-1/5000 and   0.6-
12/100000 live births respectively (deVeber et al., 2001; Lee et al., 2005; 
Laugesaar et al., 2007; Berfelo et al., 2010; van der Aa et al., 2014). Systemic 
infection, such as neonatal sepsis, is another clinical compromise that is associated 
with brain injury in the perinatal period (Mallard and Wang, 2012). 
Perinatal brain injury can lead to permanent neurological impairment that affects 
motor and cognitive functions. Cerebral palsy (CP) is the leading cause of motor 
disability in children affecting 17 million people worldwide (Graham et al., 2016). 
The prevalence of CP in a large European population was 1.9 per 1000 live births 
in 1980 and 1.77/1000 in 2003, showing a slight decrease over time (Sellier et al., 
2016).  In western Sweden, 206 children who were born between 2003 and 2006 
were later diagnosed with CP. This number indicats a prevalence of 2.18 infants 
per 1000 births. Strikingly, the CP prevalence was up to 71 per 1000 births for 
children born premature in GW<28 (Himmelmann and Uvebrant, 2014). Ex-
tremely preterm infants also present a higher prevalence of different cognitive dis-
abilities when the outcome was measured at 2.5 or 6.5 years of age in a Swedish 
study (Serenius et al., 2013; Serenius et al., 2016). Preterm birth occurs in 5-18% 
of live births, and up to 10% of extremely premature infants suffer brain injury 
(Hagberg et al., 2015; Lancet, 2016; Serenius et al., 2016) 
Hypoxic-ischemic brain injury 
HI brain injury has a complex pathophysiology that consists of three phases. The 
primary phase of injury is due to the immediate energy failure after deficit in blood 
or oxygen supply. Lack of energy causes sodium/potassium pump failure leading 
to an influx of Na+ ions, depolarization of neurons, and excessive release of the 
excitatory neurotransmitter glutamate (Hagberg et al., 2016). The glutamate-me-
diated activation of neurons results in a massive increase in intracellular calcium 
ions that activates apoptotic cell death pathways and induces the production of 
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reactive oxygen species (ROSs). The activation of these pathways causes mito-
chondrial damage (Hagberg et al., 2014), BBB disruption and brain edema, which 
altogether contributes to neural cell death by necrosis (if HI is severe) and apop-
tosis (Allen and Brandon, 2011; Thornton et al., 2012b). Following reperfusion, 
there is a latent or transient recovery period during which the oxygenation and 
metabolism of the brain returns to normal (blood reperfusion) (Gilland et al., 
1998b; Thornton et al., 2012a). Following acute ischemia, this period normally 
lasts for 6-12 hour. Next, if the initial insult is severe, a secondary energy failure 
occurs that lasts from hours to several days. It is suggested that neuronal loss dur-
ing this phase of brain injury is due to a combination of inflammation, oxidative 
stress and excitotoxicity, however the exact mechanisms are yet to be elucidated 
(Allen and Brandon, 2011; Hagberg et al., 2016). A tertiary phase of injury has 
recently been suggested to be important in the clinical outcome after HIE that in-
volves chronic inflammation, gliosis, epigenetic changes and tissue remodeling 
(Bennet et al., 2012; Fleiss and Gressens, 2012). The role of inflammation is piv-
otal in secondary and tertiary phases of brain injury, suggesting it as a potential 
target for therapeutic intervention (Hagberg et al., 2015). 
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From systemic inflammation to neuroinflam-
mation  
 
Toll-like receptors mediate inflammation 
Inflammation is a response to a stimulus, which can be a microbial component, an 
injured cell component, or a toxic compound. These stimuli all express unique and 
conserved molecular patterns such as: pathogen-associated molecular patterns 
(PAMPs) or damage-associated molecular patterns (DAMPs), which are recog-
nized by host, pattern recognition receptors (PRRs). The main family of PRRs are 
Toll-like receptors (TLRs) (Takeuchi and Akira, 2010). The name was coined due 
to the similarity between the first discovered TLR gene sequence and toll gene in 
drosophila melanogaster (O'Neill et al., 2013).  
Figure 3. Toll-like receptor signalling. Reprinted by permission from Macmillan Publish-
ers Ltd: [Nature Reviews Immunology] (O'Neill et al., 2013), copyright (2013) 
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TLR proteins are transmembrane glycoproteins that share an intracellular Toll-
like/IL1R (TIR) domain and have various leucine-rich repeat motifs in the extra-
cellular domain (Akira et al., 2006).  They are located on the cell  surface or asso-
ciated with organelles in the cytoplasm. There are 10 TLRs in humans and 13 in 
mice, each recognizing certain PAMPs and DAMPs (Fig. 3). For example, TLR4 
recognize the lipopolysaccharide (LPS) of the outer membrane of gram-negative 
bacteria, TLR2 recognizes the lipopeptides present in the cell wall of both gram-
positive and gram-negative bacteria, and TLR3 recognizes the double-stranded 
RNA of viruses (Akira et al., 2006). Some TLRs need to form homo- or heterodi-
mers in order to recognize specific ligands. For instance, the TLR1/TLR2 hetero-
dimer recognize triacylated lipoproteins of Mycoplasma pneumoniae   (Shimizu 
et al., 2007) as well as diacylated lipopeptides, while TLR2/TLR6 heterodimers 
can only recognize  diacylated lipopeptides (Jin and Lee, 2008). TLR2 has also 
been shown to form heterodimer with TLR4 to respond to hemoglobin during in-
tracerebral hemorrhage (Wang et al., 2014). TLR3 is located on endosomal mem-
branes in the cytoplasm. Upon binding of the ligand, TLR3 form homodimers and 
a signal is initiated (Jin and Lee, 2008). TLR4 extracellular domain is in a complex 
with adapter molecule myeloid differentiation protein-2 (MD2) and form homodi-
mers upon LPS binding (Kim et al., 2007).The various dimerization diversifies 
the immune responses in different immune cells (Depaolo et al., 2008; Netea et 
al., 2008; DePaolo et al., 2012).TLRs are expressed in the CNS. In the mouse brain 
the mRNA of TLR1-9 has been detected and shown to be developmentally regu-
lated (Kaul et al., 2012; Stridh et al., 2013). The protein expression of some of 
these TLRs have also been reported in different brain cell types of neonatal mouse 
(Stridh et al., 2011).  In the human brain TLR1-9 mRNA can be detected: TLR1-
9 were detected in microglia and TLR2-3 in astrocytes and oligodendrocytes 
(Bsibsi et al., 2002).  Some TLRs are also expressed on neurons of different spe-
cies including human and mouse (Rietdijk et al., 2016). In addition to their prin-
cipal function in the immune response, different TLRs play critical roles in 
neurogenesis and can have negative effects on regulation of axonal growth and 
neural progenitor proliferation (Cameron et al., 2007; Rolls et al., 2007; Lathia et 
al., 2008). Downstream of TLRs are various adapter molecules, which transfer the 
signal to corresponding transcriptions in the cytoplasm. The adapter molecules for 
TLR2 and TLR3 signaling are MyD88 (Myeloid differentiation primary response 
gene 88) and TRIF (TIR-domain-containing adapter-inducing interferon-β) re-
spectively. Activation of transcription factors (such as NF-κB) by protein modifi-
cation lead to their nuclear translocation and transcription of genes encoding, for 
example, various cytokines, including type I and II of interferons (Fig. 3) (Akira 
et al., 2006). Cytokines are signaling proteins produced by immune and non-im-
mune cells. Chemokines are chemotactic cytokines involved in cell migration. 
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They are categorized into several subfamilies (e.g. CC and CXC) based on the 
arrangement of their N-terminal cysteine residues (Zlotnik and Yoshie, 2000). 
Some chemokines have other conventional names than the CC/CXC-based names. 
For example, CCL3 is also called MIP1a. Interleukins are a large family of cyto-
kines with pro-inflammatory, anti-inflammatory or immunoregulatory functions 
(Turner et al., 2014). Tumor necrosis factor (TNF) constitutes another family of 
cytokines with various functions in immunity and cell death/survival (Brenner et 
al., 2015). 
Perinatal systemic inflammation 
 
Maternal and neonatal infections are the main cause of systemic inflammation in 
the perinatal period. Maternal infections that affect the umbilical cord and fetal 
membranes, such as funisitis and chorioamnionitis often originate from the lower 
genital tracts and are caused by multiple microorganisms, most commonly from 
the mycoplasma family, which are part of the vaginal flora in most women (Tita 
and Andrews, 2010). Other causative pathogens are gram-variable Gardnerella 
vaginalis, gram-negative bacteroides and gram-postive Group B streptococcus 
(Tita and Andrews, 2010). Human and animal studies show that maternal infec-
tions induce an elevation in certain inflammatory cytokines in maternal and fetal 
blood, as well as in the neonate’s brain (Dammann and Leviton, 1997; Laborada 
and Nesin, 2005). For example, chorioamnionitis in humans cause an elevation of 
interleukin 6 (IL6) and granulocyte-colony stimulating factor (G-CSF) in both ma-
ternal and fetal blood, and an increase in IL6 and IL8 in the newborn’s CSF (Dam-
mann and Leviton, 1997; Laborada and Nesin, 2005). Maternal infection may also 
lead to fetal inflammatory response syndrome (FIRS) in preterm infants, an acute 
systemic inflammation characterized by elevated IL6 in cord blood plasma and 
neutrophilia (Bonadio, 2016).  
 
Among the causes of inflammation are also viral infections. Many neurotropic 
viruses including herpes-simplex virus, herpes virus, cytomegalovirus (CMV) and 
Epstein-bar viruses are able to pass the placenta, and increase the risk of preterm 
birth and cerebral palsy (Gibson et al., 2006). CMV is the most common congen-
ital viral infection in developed countries. It is transmitted from the mother with 
primary and recurrent CMV infection to the fetus during pregnancy with a trans-
mission rate of 32% and 1.4% respectively (Kenneson and Cannon, 2007). CMV 
induces a pro-inflammatory cytokine release in the placenta and amniotic fluid of 
pregnant women (Scott et al., 2012). It also induces an interferon response in the 
developing brain of mice (van den Pol et al., 2007). Congenital CMV infection is 
associated with permanent disabilities such as hearing loss and mental retardation 
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(Naing et al., 2016).  
 
Neonatal infections are major causes of mortality and morbidity in the first month 
of life. Approximately 1% of all newborns in developed countries are affected by 
infections in the neonatal period (Vergnano et al., 2011). These infections often 
lead to sepsis, meningitis and/or pneumonia (Heath and Jardine, 2014). Sepsis has 
recently been re-defined as “a life-threatening organ dysfunction caused by a 
dysregulated host response to infection” (Singer et al., 2016). In other words, sep-
sis is a severe and serious systemic inflammation in response to infections. Neo-
natal sepsis and meningitis were the causative factors for ~7% (0.4 million) of all 
global deaths of children under the age of 5  in 2015, while preterm birth remained 
the leading cause of mortality in this group (~16%; 0.9 million)  (Liu et al., 2016). 
Preterm infants are, in particular, susceptible to invasive infections (Strunk et al., 
2014). Neonatal sepsis is divided into two categories: early-onset (EONS, 0-7 days 
of age) and late-onset (LONS, 8-28 days of age). EONS is believed to originate 
from the placenta or maternal genital tracts, while LONS can be nosocomial or 
from the community environment (Dong and Speer, 2014). In developed coun-
tries, the major pathogens for EONS are Group B streptococcus (GBS) and Esch-
erichia coli (E-coli) (Simonsen et al., 2014; Schrag et al., 2016) and for LONS 
coagulase-negative staphylococci such as Staphylococcus epidermidis. In devel-
oping countries Klebsiella species, E-coli, Staphylococcus aureus, GBS are the 
main causes of EONS and gram-positives such as Streptococcus and Staphylococ-
cus species are the pathogens causing LONS (Obiero et al., 2015). The very low 
birth weight infants are more vulnerable to EONS particularly to gram-negative 
infections (Wynn and Levy, 2010). 
 
Necrotizing entrocolitis (NEC) is a severe intestinal disease, mostly in preterm 
infants, and associated with a systemic inflammatory response (Neu and Walker, 
2011). Another cause of systemic inflammation, predominantly affecting the very 
preterm infant, is severe lung disease requiring mechanical ventilation. In addition 
to inflammation, respiratory support may cause fluctuations in cerebral blood flow 
that add to the increased risk of brain injury (Polglase et al., 2014). Severe respir-
atory conditions in the term infants, such as meconium aspiration, are also fol-
lowed by a systemic inflammatory response (Reuter et al., 2014).  
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Inflammatory cells in circulation 
 
In addition to a surge of various cytokines into the circulation, systemic inflam-
mation is associated with a marked change in the diversity and quantity of blood 
leukocytes. The reference range for white blood cell counts in newborns in their 
first month of life are: 9100-34000 white blood cells (WBC)/µm3, 32-67% seg-
mented neutrophils, 0-8% band neutrophils, 25-37% lymphocyte, 0-9% mono-
cytes, 0-2% eosinophils and 0-1% basophils (Andropoulos, 2012). Many factors 
might influence the values including: infant age in hours and gender, as well as 
maternal factors (Thomas et al., 2010). The reference is of limited value for pre-
term infants due to large variabilities (Maheshwari, 2014). There is also diversity 
in the subtype of cells present within different populations of leukocytes. For ex-
ample, circulating monocytes of human and mouse are categorized into inflam-
matory (CD14+CD16+ and CD14+CD16−, human) and patrolling (CD14dimCD16+, 
human) based on their surface marker expression.  The former has a role in in-
flammatory response to bacterial pathogens, while the latter has roles in tissue 
repair and inflammatory response to viruses (Cros et al., 2010; van de Veerdonk 
and Netea, 2010). 
 
TLRs are expressed on human neonatal blood monocytes, neutrophils and lym-
phocytes at comparable levels to adults (Viemann et al., 2005; Dasari et al., 2011), 
however, some differences, for example in TLR3 expression, has been reported 
between neonatal and adult leukocytes (Slavica et al., 2013). During neonatal sep-
sis TLR2 (but not TLR4) expression is transiently increased on monocytes (Vie-
mann et al., 2005). However, the phagocytic activity of neutrophils and monocytes 
is defective in newborns in their first 3 days of life (Filias et al., 2011). Moreover, 
exposure to pathogens also reduces the phagocytic activity of these cells, predis-
posing the neonates to sepsis (Silveira-Lessa et al., 2016). Newborns with infec-
tions have lower WBC and neutrophils count and larger proportion of immature 
neutrophils when assessed <24h of life compared to the age-matched non-infected 
newborns (Thomas et al., 2010). The number of CD14dimCD16+ and 
CD14highCD16+ monocytes is increased in newborns with sepsis (Skrzeczyñska et 
al., 2002). Lymphocyte count >95th percentile or <5th percentile is also associated 
with EONS (Christensen et al., 2012).  
 
Neuroinflammation 
 
What conditions lead to the breach of the tightly homeostatic system of the brain 
and neuroinflammation? CNS infections leading to meningitis or encephalitis are 
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naturally the first plausible cause of neuroinflammation. Meningitis is the inflam-
mation of CNS meningeal membranes in response to infections (Kim, 2010). Ne-
onatal meningitis is usually associated with sepsis, particularly EONS (Simonsen 
et al., 2014). GBS, E-coli, Listeria monocytogenes, Streptococcus pneumoniae are 
main pathogens causing meningitis. With development of vaccines, meningitis in-
cidence due to Neisseria meningitidis and Haemophilus influenza, the classical 
meningitis pathogens,  has decreased (Kim, 2010). Any local injury (e.g. HI) in 
the CNS also triggers an inflammatory response. Moreover, some autoimmune 
diseases such as multiple sclerosis also involves the  CNS, resulting in severe in-
flammation in the brain (Becher et al., 2017).  
Peripheral inflammation, particularly systemic inflammatory conditions like sep-
sis, can affect the immune homeostasis of the CNS and its function. Adult sepsis 
frequently leads to septic encephalopathy (Dal-Pizzol et al., 2014) and long-term 
cognitive decline (Annane and Sharshar, 2015). However, direct evidence for an 
association of systemic inflammation with neuroinflammation is scarce in hu-
mans, as accessing relevant tissue is difficult.. In postmortem brains of adult pa-
tients, that died of septic shock, an increased expression of the inflammatory 
cytokine TNF-a was observed in glial cells and induced nitric oxide synthase 
(iNOS) was detected in the vasculature, which was associated with apoptosis in 
neurons (Sharshar et al., 2003). In another study, an elevation of chemokines 
CXCL8, CXCL10, CXCL12, CCL13 and CCL22 was detected in brains of pa-
tients that died of sepsis complications (Warford et al., 2017). In preterm infants 
with EONS, the level of TNF-a and IL1-b was higher in plasma and CSF com-
pared to age-matched controls. (Basu et al., 2015). There are more studies on hu-
man preterm infants with documented neuroinflammation; however, it is not 
possible to attribute the effect only to systemic inflammation or sepsis due to the 
often-multifactorial nature of the pathology and death. There are a few experi-
mental studies in adult humans connecting systemic inflammation to brain func-
tion, however the presence of neuroinflammation was not investigated (Krabbe et 
al., 2005; van den Boogaard et al., 2010; Kullmann et al., 2014). For example, 
systemic administration of a low dose E-coli endotoxin (0.2 ng/kg) in humans did 
not change the plasma level of the stress hormone cortisol, but increased the cyto-
kines TNF-a and IL6, which was associated with a decline in declarative memory 
performance (Krabbe et al., 2005). It should also be noted that the dosages used 
in these endotoxemia models are understandably far lower than those measured in 
plasma of sepsis patients (Marshall et al., 2002).  
Altogether, the human data suggest that peripheral systemic inflammation can in-
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duce neuroinflammation and alter the brain function. However, there is more sup-
porting evidence from data in experimental animal models. In adult mouse and rat 
models of sepsis, induced by cecal ligation and perforation, increased leukocyte 
trafficking was observed in brain vasculature in addition to release of several cy-
tokines and chemokines in the brain (Comim et al., 2011). This was followed by 
an increase in BBB permeability in several regions of the brain and brain autono-
mous dysfunction. Likewise, systemic infection of neonatal mouse with Staphy-
lococcus epidermidis, without bacteria presence in the CSF, significantly 
upregulated expression level of several inflammatory genes in the brain (Bi et al., 
2015). In an LPS (5mg/kg)-induced sepsis model in the adult mouse, a sustained 
activation of microglia cells and release of pro-inflammatory cytokines was iden-
tified in the brain (Weberpals et al., 2009). Similar inflammatory responses have 
been reported with LPS administration in neonatal rat, mouse and sheep (Mallard 
et al., 2003; Smith et al., 2014; Patil et al., 2016). Moreover, intra-amniotic in-
flammation is associated with subsequent neuroinflammation in neonates in ex-
perimental animal models (Bell and Hallenbeck, 2002; Schmidt et al., 2016). 
Thus, these experimental studies show that systemic inflammation can induce neu-
roinflammation. 
Several mechanisms have been suggested to communicate the systemic inflam-
mation to the CNS (Fig. 4).  Systemic infections (e.g. sepsis) result in the release 
of several PAMPs and DAMPs, as well as several inflammatory cytokines in the 
circulation. These compounds can stimulate the PRRs at the brain interfaces (e.g. 
choroid plexus), leading to the release of inflammatory mediators into the CNS 
and/or leukocyte recruitment. In support, it has been shown that activation of 
TLR4 in the adult mouse can induce neuroinflammation independent of peripheral 
inflammation suggesting that activation of TLR4 at the brain interfaces is suffi-
cient for the inflammatory effect in the CNS (Chakravarty and Herkenham, 2005).  
In addition, these compounds can cause alterations in the brain barriers, leading to 
increased permeability that might facilitate the communication of inflammatory 
molecules and cells. This is further discussed in the next sections. 
Figure 4. The possible mechanisms of neuroinflammation due to systemic inflamma-
tion/infections. 
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Brain vasculature in mediating inflammation 
Inflammatory mediators in the periphery can reach the CNS via an intact, altered 
or disrupted BBB (Varatharaj and Galea, 2017). Some cytokines can be trans-
ported from blood to the brain by specific saturable transporters. The rate of 
transport is dependent on the cytokine type and the brain region (Banks, 2005). 
Polarized nature of endothelial cells also enables them to act as communicators 
between the luminal (blood side) and abluminal (brain side) sides. Therefore, stim-
ulation of the luminal side with  PAMPs leads to the release of cytokines to the 
abluminal side, and vice versa (Banks et al., 2009). Systemic infection/inflamma-
tion such as in sepsis is also associated with disruption of BBB that might further 
enhance the neuroinflammation (Gofton and Young, 2012).  
Leukocytes can pass the BBB in various brain pathologies. The transmigration 
occurs mainly at capillaries and post-capillary venules, however, other parts of 
brain vasculature may also be a route of entry (Larochelle et al., 2011). Lep-
tomeningeal vessels has been recently shown to be the main route of effector T 
cell migration to the CSF and brain parenchyma during experimental autoimmune 
encephalomyelitis (EAE), an animal model for multiple sclerosis (Schläger et al., 
2016).  
Choroid plexus in mediating inflammation 
There are several studies supporting the role of choroid plexus in mediating pe-
ripheral inflammation to the CNS and contributing to neuroinflammation. In re-
sponse to peripheral LPS administration, the expression of several inflammatory 
cytokines and chemokines was upregulated in adult mouse choroid plexus 
(Marques et al., 2007; Marques et al., 2009b; Marques et al., 2009a). Moreover, 
choroid plexus epithelial cells produce a panel of cytokines and chemokines in 
response to meninigitis-causing bacteria, such as Neisseria meningitidis (Stein-
mann et al., 2013; Borkowski et al., 2014). Recently, it was demonstrated in two 
adult mouse models of systemic inflammation (LPS injection or cecum ligation) 
that extracellular vesicles containing microRNA are secreted by the choroid 
plexus into the CSF. These microRNAs are taken up by microglia and astrocytes 
leading to up-regulation of pro-inflammatory genes (Balusu et al., 2016b). The 
choroid plexus has also been suggested as an invasion route of inflammatory leu-
kocytes into the CNS in many pathologies such as meningitis, multiple sclerosis 
and brain trauma (Reboldi et al., 2009; Wewer et al., 2011; Schmitt et al., 2012; 
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Szmydynger-Chodobska et al., 2012). However, recent advances revealed that the 
choroid plexus could also act as an educational gate for trafficking of anti-inflam-
matory and beneficial immune cells to the CNS during, for example, spinal cord 
injuries (Shechter et al., 2013; Schwartz and Baruch, 2014). The role of TLRs in 
the choroid plexus in the communication between systemic inflammation and the 
brain has not been investigated. Expression of many TLRs has been shown in 
mouse choroid plexus and human choroid plexus papilloma cells, but to date no 
data is available from healthy human choroid plexus (Stridh et al., 2013; Borkow-
ski et al., 2014; Schwerk et al., 2015). 
Immune cells in neuroinflammation 
As mentioned, microglia cells are the most abundant professional immune cells in 
the brain parenchyma. Similar to peripheral macrophages, microglia have conven-
tionally been categorized into two phenotypes, M1 and M2, based on expression 
of specific cell markers. The M1 phenotype is considered pro-inflammatory and 
is identified by expression of markers such as TNF-a, iNOS, major histocompati-
bility complex (MHC II), IL-6, and CD86. The M2 anti-inflammatory reparative 
phenotype is identified by markers such as arginase-1, CD206, transforming 
growth factor beta (TGF-b) and IL-10. M2 phenotype is involved in phagocytosis 
of debris and dead cells, resolution of inflammation, remodeling of axons, oli-
godendrogenesis and neurogenesis (Hu et al., 2015).  In response to external stim-
uli, microglia develop different phenotypes with various functions (Chhor et al., 
2013). However, the paradigm of M1/M2 phenotypes of microglia that has arisen 
from in vitro studies has been criticized for oversimplification of the biologically 
complex immune state of microglia in vivo (Hu et al., 2015). In support, neonatal 
HI induces various microglia phenotypes in the brain, including mixed classical 
(M1) and alternative (M2) phenotypes (Hellstrom Erkenstam et al., 2016).  
There are several studies showing that systemic inflammation induced by periph-
eral administration of LPS or bacteria leads to microglia activation and upregula-
tion of pro-inflammatory genes such as TNF-a and IL1-b (systematically reviewed 
in (Hoogland et al., 2015)). Recently, it was discovered that activated microglia 
cells release TNF-a, IL1-a and C1q, which induce a reactive phenotype of astro-
cytes termed A1 which is dysfunctional, toxic to neurons and oligodendrocytes 
and destructive to synapses (Liddelow et al., 2017). Both microglia and astrocytes 
maintain the activated phenotype long after neonatal HI (Bona et al., 1999). In-
duction of cytokines by microglia is dependent on expression of Peli1, a regulator 
of TLR signaling (Xiao et al., 2013). 
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Microglia and astroglia cells might also mediate leukocyte recruitment to the CNS 
when there is a local or systemic infection/injury (Babcock et al., 2003). For ex-
ample, in the adult mouse with inflammatory liver injury, circulating TNF-a acti-
vates microglia cells which in turn produce CCL2 (monocyte chemoattractant 
protein 1, MCP-1) leading to recruitment of peripheral monocytes to the brain 
(D'Mello et al., 2009).   Infiltrating leukocytes can promote the neuroinflammatory 
milieu by production of inflammatory cytokines and paving the way for further 
communication between the peripheral immune system and the CNS. For in-
stance, it has been suggested that  CNS-invading T cells in a multiple sclerosis 
animal model, EAE, might mediate recruitment of peripheral myeloid cells to the 
brain and also activate CNS resident macrophages (Becher et al., 2017). The in-
filtrating monocytes during EAE contribute to the pathology and differentiate into 
resident macrophages and dendritic cells. (King et al., 2009). HI in neonatal mice 
is also associated with long-lasting T cell infiltration to the brain (Winerdal et al., 
2012). Leukocyte infiltration to the CSF is also a hallmark of meningitis in new-
borns and adults (Kim, 2010). Moreover, 9% of preterm infants with abnormalities 
observed in their brain scans have increased number of leukocytes in their CSF 
(Viscardi et al., 2004).  
Inflammation and brain injury 
The notion of inflammation/infection being involved in neonatal encephalopathy 
stems from several clinical studies. Maternal infections such as funisitis, chori-
oamnionitis, urinary and respiratory tract infections increase the risk of cerebral 
palsy in newborns (Grether and Nelson, 1997; Miller et al., 2013; Bear and Wu, 
2016). Maternal infections also increase the risk of EONS, pneumonia, asphyxia, 
intraventricular hemorrhage (IVH) and white matter damage in the newborn (Tita 
and Andrews, 2010; Nelson and Penn, 2015). Chorioamnionitis is a common preg-
nancy complication associated with 32% of preterm births (Yoon et al., 2001) and 
up to 13% of term births (Tita and Andrews, 2010). Maternal inflammation has 
been associated with increased risk of neurodevelopmental disorders such as 
schizophrenia and autism (Knuesel et al., 2014). Moreover, preterm infants with 
FIRS have a higher risk of suffering from severe forms of PVL and IVH (Hofer et 
al., 2013). Preterm infants with sepsis or NEC have a higher risk of white matter 
injury and motor impairment at 2 years of age (Shah et al., 2008; Basu et al., 2015).  
 
Term neonates who develop cerebral palsy also show significant elevation of 
chemokines such as CCL3 and CCL4 (also known as MIP1-a and MIP1-b, respec-
tively), RANTES (regulated on activation, normal T cell expressed and secreted) 
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and MCP-1 in blood (sampled at 1-18 days of age), suggesting ongoing systemic 
inflammation (Nelson et al., 1998). Children with cerebral palsy also show an al-
tered immune system with high level of inflammatory molecules in the blood 
(Grether and Nelson, 1997). Asphyxiated neonates have an increased amount of 
inflammatory cytokines IL-6 and IL-8 in the CSF that is associated with more 
severe HIE (Savman et al., 1998) suggesting a neuroinflammatory component of  
the  injury process. Altogether, human studies suggest  inflammation as a major 
risk factor for perinatal brain injury including HIE (reviewed in (Hagberg et al., 
2015)).  
 
The underlying mechanisms of inflammation-induced injury have been studied in 
various animal models. Neonatal mice injected intraperitoneally with various in-
flammatory cytokines, such as IL1-b, developed larger injuries to subsequent ex-
citotoxic insult (by intracerebral injection of glutamate analogues), an effect that 
was mediated by prostaglandin production in the brain (Dommergues et al., 2000; 
Favrais et al., 2007). The inflammation-induced increase in excitotoxicity was due 
to downregulation of  G protein-coupled receptor kinase 2 (GRK2) a key molecule 
in regulating glutamate receptors (Degos et al., 2013).  Systemic activation of 
TLR4 by LPS before HI sensitizes the brain to the injury through the MyD88 
pathway by inducing a systemic inflammation (Eklind et al., 2001; Eklind et al., 
2005; Wang et al., 2009a). The mouse pups that received LPS prior to HI had 
greater brain tissue loss and poor myelination, suggesting aggravated injury in 
both grey and white matter. Activation of microglial TLR4 leads to axonal and 
neuronal loss in vitro and in vivo  in a mouse model of neonatal HI (Lehnardt et 
al., 2003). However, the effect of LPS depends on the interval between endotoxin 
injection and HI, and the LPS dosage. LPS injection 6 hours or 72 hours before 
HI increases the brain injury, while LPS administration 24 hour before HI induce 
preconditioning effect with improved HI outcome (Eklind et al., 2005). The pro-
tective effect was associated with up-regulation of corticosterone in rat pups 
(Ikeda et al., 2006). The link between LPS-induced systemic inflammation and 
increased vulnerability of the neonatal brain to HI is not fully understood. How-
ever, neuroprotective effect of N-acetylcysteine (NAC), a common antioxidant 
reagent, in a LPS-sensitized HI model suggests a role for ROS in meditating sen-
sitization to the brain injury (Wang et al., 2007). In addition, blocking lymphocyte 
trafficking in the same model ameliorated the injury, suggesting a contribution of 
peripheral immune cells to brain damage (Yang et al., 2014), which is consistent 
with stroke model studies in adult mouse (Liesz et al., 2011; Lee et al., 2014). The 
LPS sensitization effect was also abolished in neonatal mice lacking TNF gene 
cluster, suggesting a detrimental role of these cytokines (Kendall et al., 2011).  
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It has been shown that systemic activation of TLR3 induces neural apoptosis and 
accelerates prion-induced neurodegeneration (Field et al., 2010) and also nigro-
striatal dopaminergic degeneration similar to Parkinson disease (Deleidi et al., 
2010). However,  TLR3 deficiency is not neuroprotective in an adult mice stroke 
model (Famakin et al., 2011). Maternal immune activation by TLR3 ligand, Poly-
inosinic:polycytidylic acid (Poly I:C), causes changes in mouse fetal brain leading 
to exploratory and social deficits in offspring; an effect that is mediated by IL-6 
(Smith et al., 2007). However, the impact of TLR3 activation on neonatal HI has 
not been studied. 
TLR2 activation by intrathecal administration of Pam3CSK4 (P3C) causes leuko-
cyte infiltration to the brain and neuronal loss due to apoptosis (Hoffmann et al., 
2007). However,  in vitro treatment of neurons with the TLR2 ligand did not lead 
to neural death suggesting the effect is mediated by inflammation rather than di-
rect cytotoxicity of P3C (Hoffmann et al., 2007). Interestingly, TLR2 deficiency 
exacerbates ischemic brain injury in adult mice (Choi et al.; Bohacek et al., 2012). 
In contrast, activation of TLR2 and TLR4 of brain infiltrating macrophages by 
peroxiredoxin proteins released from necrotic neurons increases the ischemic in-
jury, suggesting peroxiredoxin as a potential target in treatment of strokes (Shi-
chita et al., 2012). However, TLR2 deficiency is neuroprotective in a mouse model 
of HI (Stridh et al., 2011). Whether activation of TLR2 contributes to brain injury 
in neonatal HI, and the underlying mechanisms, has not been investigated. 
Systemic inflammation might also affect the functions of other peripheral organs 
leading to CNS sensitization to injury. For instance, it might prime or exacerbate 
respiratory distress, contributing to hypoxia (Speer, 2009, 2011; Forsberg et al., 
2016). Furthermore, there is evidence for a detrimental effect of systemic inflam-
mation on mitochondrial function (Jeger et al., 2013) suggesting another potential 
link between inflammation and HI brain injury .          
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Aims 
 
The overall aim of the thesis project is to address the question: how is systemic 
inflammation communicated to the developing brain and affects the hypoxic/is-
chemic brain injury?  
The specific aims are: 
• To test the hypothesis that systemic activation of TLR3 signalling has an 
impact on neonatal HI  
• To test the hypothesis that systemic activation of TLR2 signalling has an 
impact on neonatal HI  
• To test the hypothesis that activation of different TLRs in the periphery 
induce a specific inflammatory profile in the CNS  
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Methodological considerations 
 
Laboratory animals  
 
Neonatal mice (Paper I-IV) and rats (V) were used as animal models in research 
projects for this thesis. In Paper III, we also used adult mice in one experiment. 
The use of mice and rats to model human diseases has revolutionized the biomed-
ical sciences in the last century. Particularly, using transgenic mice has substan-
tially contributed to our understanding of molecular mechanisms of many 
diseases. However, in spite of remarkable similarity between the human and ro-
dent genome, there are considerable differences at the organ, cellular and molec-
ular level between these species.  
 
The adult mouse brain weighs ca 0.5 gr, almost 3000 times lighter than the human 
brain (1500 gr). It contains 71 million neurons, which is almost 1200 times less 
than that of human brain (86 billion) (Azevedo et al., 2009). The mouse brain lacks 
gyri, the special cortical folding that is highly consistent between human individ-
uals and increases the cortical grey matter surface area and volume (White et al., 
2010). Moreover, the white/grey matter ratio and cerebral blood flow regulation 
is different in rodents compared to humans (Mallard and Vexler, 2015a). Rodents 
also are born relatively more immature, and many developmental events in the 
brain occur postnatally compared to humans. We used pups at postnatal day 
(PND) 8-9, which in terms of brain development roughly corresponds to human 
infants at near-term age based on several anatomical and functional factors (Hag-
berg et al., 2002b; Craig et al., 2003; Workman et al., 2013).  
 
The immune system of rodents have many similarities, but also some important 
differences compared to humans. This has recently been debated after a study pub-
lished by Seok et al claimed that human gene responses to inflammatory condi-
tions are poorly mimicked in mouse models (Seok et al., 2013). Two years later 
Takao and Miyakawa re-evaluated the same data as Seok et al and concluded that 
that the gene response to inflammatory conditions in mouse models highly mimics 
human conditions with 59.5–93.2% of gene changes in the same direction (Takao 
and Miyakawa, 2015). The difference between human and mouse immune re-
sponses in addition to the genetic factors, might be influenced by the laboratory 
conditions. It has been shown that a pathogen-free environment impedes the full 
development of the mouse immune system, making them resemble the immature 
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immune system of the human neonate (Beura et al., 2016). However, normalizing 
the environment for the mice enhance the similarities to that of the adult human 
(Beura et al., 2016). The standardization of these “normalized” conditions might 
be a challenging impediment requiring extensive studies. Therefore in our study, 
the mice and rats were housed in standard pathogen-free ventilated cages with ad 
libitum access to food and water and 12h light/dark cycle.  
 
The following mice and rat strains were used in this thesis: 
- C57Bl6/J is the most used inbred wild type mouse strain (Paper I-V) 
- TRIF knock-out (KO) (C57BL/6J–Ticam1Lps2/J; Jackson Laboratory) 
are the mice lacking the adapter molecule for TLR3, TRIF (Paper I) 
- TLR2 KO (B6.129-Tlr2tm1Kir/J; Jackson Laboratory) (Paper II, III) 
- Lys-EGFP-ki are mice in which peripheral myeloid cells express the 
green fluorescence protein (Paper III) 
- MyD88 KO (B6.129P2(SJL)-Myd88tm1.1Defr/J; Stock No: 009088; 
Jackson Laboratory) are mice lacking the adapter molecule downstream 
of TLR2, TLR4 and IL1R (Paper III) 
- MyD88 flox (B6.129P2(SJL)-Myd88tm1Defr/J; Stock No: 008888; 
Jackson Laboratory) are mice in which two inserted loxP genes flanks 
the MyD88 gene enabling Cre recombinase-mediated gene knock-out 
(Paper IV) 
- Sprague-Dawley and Wistar rats are outbred rats widely used in biomed-
ical research (Paper V)  
 
For experiments on transgenic knockout mice, littermates were used in order to 
assure that genetic background of the pups and the environment remain compara-
ble (Holmdahl and Malissen, 2012). We bred female and male mice that were 
heterozygous for the knockout gene, and the pups that were gene knockout or wild 
type were identified by genotyping and used in the studies.  
 
TLR agonists  
 
Poly I:C (paper I) is a synthetic mimic of viral double-stranded RNA (dsRNA). A 
class of viruses have dsRNA as their genomic component (e.g. Reoviridae). In 
single-stranded positive-sense RNA viruses (e.g. picornavirus) and DNA viruses 
(e.g. Herpesviridae ), dsRNA is a bi-product of viral replication (Weber et al., 
2006). The TLR3 ecotodomain binds the dsRNA of at least 40-50 base pair length 
in cytoplasmic endosomes (Liu et al., 2008).  
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Pam3CSK4 (P3C, paper II-V) is a synthetic lipopeptide constructed of three fatty 
acid pamitoyl molecules linked to amino acids cysteine, serine and lysine. 
Lipopeptides are cell wall components of gram-positive and gram-negative bacte-
ria with various roles in bacterial growth, colonization, antigenicity and signal 
transduction (Kovacs-Simon et al., 2011). The lipid chain of P3C induces hetero-
dimerization of TLR1 and TLR2, which in turn induces dimerization of their TIR 
domain and initiates intracellular signaling (Jin et al., 2007).  
 
Lipopolysaccharide (LPS, paper III and IV) is the major component of the outer 
membrane in gram-negative bacteria. It consists of three elements: lipid A, core 
oligosaccharide and O antigen polysaccharide. The O antigen is structurally vari-
able which gives rise to several serotypes (Maldonado et al., 2016). Lipid A makes 
a hydrogen bound to MD2 of  the TLR4-MD2 complex leading to TLR4-mediated 
activation (Park et al., 2009). We used ultra-pure LPS from E.coli serotype 
O55:B5 which is a common enteropathogenic strain (Rodrigues et al., 1996). Due 
to batch-to-batch variations associated with purified LPS, we used the same batch 
in all experiments.   
 
All TLR agonists were injected intraperitoneally at a consistent volume of 10 µl/g 
body weight. After the injection, the pups were held in the hand briefly to assure 
that there was no leak-out of injected agonsits. The dosages were selected based 
on our or others’ previous studies.   
 
Hypoxic-ischemic brain injury model  
 
The HI brain injury model used in this thesis is induced by permanent ligation of 
the left carotid artery in mouse pups at PND9 followed by an hour of rest with the 
dam and then exposure to hypoxia. The length of the surgical operation should be 
consistent and kept at a minimum since prolonged exposure to the anesthesia com-
pound isoflurane might exert a neuroprotective effect (Chen et al., 2011; Burchell 
et al., 2013). The operated mice are kept on a warm pad (35°C) to avoid hypother-
mia. After the rest period, pups are placed in a chamber with a tightly controlled 
temperature of 36°C. The chamber is first ventilated for 10 minutes with humidi-
fied warm air, followed by 50 minutes of hypoxia (air mixed with nitrogen to 
adjust the oxygen to 10%) and then 10 minutes of air only. The neonatal model, 
often referred to as the Rice-Vannucci model, was first described in rats (Rice et 
al., 1981) and then modified for use in mice (Ditelberg et al., 1996). The ad-
vantages of the model are its unilateral form of injury that leaves the contralateral 
hemisphere as an internal control and that the extent of the injury can be controlled 
by the length of the hypoxia, although the model does produce high inter-animal 
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variability. The injury pattern is fairly similar between PND9 mouse HI and hu-
man term infant HIE. Basal ganglia and thalamus are the main sites of injury in 
HIE infants; the cortex can be involved if the injury is severe (Miller and Ferriero, 
2009). These regions are also affected in the mouse HI model; however, the loss 
of hippocampal tissue is usually more prominent in the mouse. The damage to 
white matter is also present in both human and mouse HI brain injury (Miller and 
Ferriero, 2009; Mallard and Vexler, 2015b).  
 
Immunohistochemistry and histology 
 
Immunohistochemistry (IHC) is a method in which a target protein is detected 
visually in a tissue by immunolabelling. The tissues in this thesis were processed 
in different ways prior to IHC: In paper I and II, paraformaldehyde (PFA)-fixed 
brain tissues were dehydrated and then embedded in paraffin. Paraffin-embedded 
tissues has the advantage that cutting thin sections (10 µm in paper I and II) is 
possible and that the tissue morphology is highly preserved. In paper III, PFA-
fixed brain tissue were cryopreserved in sucrose and then frozen. Thick sections 
(40 μm) were cut on a cryostat and were kept in -20°C freezer in a cryoprotectant 
solution. Free-floating immunostaining has the advantage of better antibody pen-
etration in a thick section but handling the tissue can be troublesome. IHC on thick 
sections provides more information on the tissues three-dimensional structure and 
the protein localization. In paper V, whole choroid plexus tissue was fixed in PFA 
and then immunolabeled, which helped to identify limited numbers of infiltrating 
cells in a small tissue sample. 
 
The localization of the target protein and an estimation of its expression level can 
be acquired by IHC. A simple IHC procedure include antigen retrieval (optional), 
blocking of non-specific binding sites, primary antibody incubation, secondary 
antibody incubation and visualization. The primary antibody is raised in and puri-
fied from an animal species, and usually is an IgG class of immunoglobulins. The 
secondary antibody is raised against the primary Ig molecule (usually the class-
specific heavy chain of Ig) in a different species, therefore it reacts with the pri-
mary antibody at several sites and amplifies the signal. The secondary antibody is 
modified in a way that it can be visualized by microscopy. This modification is 
commonly a fusion with a fluorescent molecule or an enzyme that reacts with cer-
tain substrates, producing a color.  
 
Tissue processing is an important step in IHC. The tissue is usually immediately 
fixed with a fixative to preserve the protein structures. PFA is the most commonly 
used fixative, which acts by cross-linking proteins. The cross-linking is initiated 
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by covalently linking primary amines, purines and thiols (24-48h) and is continued 
by involving other functional groups such as amides (Thavarajah et al., 2012). The 
cross-links can be reversed by a procedure called antigen retrieval that exposes 
the antigenic sites of the protein to the primary antibody. Antigen retrieval is 
achieved by heating the fixed tissue sections or/and the use of detergents (Fowler 
et al., 2011). In Paper I, II and III, the antigen retrieval was performed by heating 
the sections in citric buffer. The non-specific binding site was blocked by incubat-
ing the sections with blood serum containing various proteins or a serum purified 
protein such as albumin. After incubation with primary antibodies, a biotinylated 
secondary antibody was added.  Next, an avidin/streptavidin-conjugated horserad-
ish peroxidase was incubated with the sections. Avidin/streptavidin form a very 
strong non-covalent binding to biotin. Peroxidase in presence of hydrogen perox-
ide oxidizes the substrate, 3,3′-Diaminobenzidine (DAB), producing a visible re-
action product.   
 
Free-floating sections were stained using fluorescent-conjugated secondary anti-
bodies. In paper V whole choroid plexus was dissected out, briefly fixed in PFA 
and stained using fluorescent-conjugated antibodies. We used Triton X-100, a 
strong detergent, to enhance tissue permeability and antigen availability in free-
floating brain sections and whole-mount choroid plexus staining. 
 
To visualize the staining, a bright-field microscope was used for DAB stained thin 
sections and a confocal fluorescence microscope for free-floating or whole-mount 
samples stained with fluorescent antibodies. The confocal microscope has some 
advantages over conventional fluorescence microscopes including less out-of-fo-
cus blurring, better resolution and greater focal depth.  
 
In an unpublished experiment related to Paper II, we performed IHC to visualize 
microglia cells. Microglia cells were stained for Iba-1 (Wako polyclonal rabbit 
anti-Iba1; 1:2000) following a standard protocol used in Paper I and II.  
 
In a histology experiment related to Paper II but not previously published (Fig. 
10), brain tissue sections were stained with thionin/acid fuchsin. Briefly, after de-
paraffinization and rehydrating the sections, slides were dipped in 1% thionin/to-
luidine solution for 4 minutes, followed by 30 seconds dip in acid fuchsin. After 
rinsing in water, sections were dehydrated and mounted with coverslips. Neuro-
pathology scoring was performed as described previously (Wang et al., 2009a).  
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Brain injury assessment 
 
For measuring the extent of injury, we performed IHC to visualize microtubule-
associated protein 2 (MAP2) and myelin basic protein (MBP). MAP2 is a specific 
marker for neurons and thus is commonly used to measure neural loss (Gilland et 
al., 1998a). MAP2 is involved in stabilizing the microtubule structure in neurons. 
There are three isoforms of MAP2 (Dehmelt and Halpain, 2005) and the HM2 
clone of the antibody used in our study reacts with all of them. MBP constitute 
30% of the total protein content of the neural myelin sheath and is one of the most 
abundant proteins in the CNS (Boggs, 2006). MBP staining is commonly used to 
detect damage to the white matter.  
 
The neural tissue damage was calculated as a percentage of neural loss in relation 
to the contralateral (uninjured) hemisphere as:  
 
Tissue loss percentage = (Ac-Ai)/ Ac x 100 
 
Ac is MAP2-stained area in contralateral hemisphere and Ai is MAP2-stained area 
in ipsilateral (injured hemisphere).  
 
By normalizing the tissue loss to the area of the uninjured hemisphere, the varia-
bility in section/tissue size that might be introduced during tissue processing is 
avoided. Five coronal sections at five different levels of the brain were analyzed 
from each animal which enabled us to obtain an overall assessment of the brain 
injury in different regions of the brain.  
 
The white matter damage or myelin loss (MBP) was calculated using the same 
formula but only three levels of the brain were analyzed. The MBP-positive area 
was measured in subcortical white matter. The number of animals used in this 
experiment is based on our previous studies using the same model.   
 
In an experiment related to Paper II (Fig. 11), we stained for microglia cells in the 
brain sections. To count the cells in an unbiased manner, we performed stereology 
which is a method to obtain quantitative information with three-dimensional prop-
erty from a two-dimensional section (Mühlfeld et al., 2010). A Leica DM600 mi-
croscope was used together with a stereology software, Stereo Investigator. A 
Fractionator method was used for quantification.  
 
 
 
  
M ETHODO LOGIC AL C ONSIDERATIONS    27 
Quantitative reverse transcription PCR 
 
Quantitative reverse transcription polymerase chain reaction (RT-qPCR) is the 
most commonly used method for quantification of gene expression. We performed 
a two-step RT-qPCR in paper I to quantify the mRNA of several genes in the 
mouse brain. The first step is the reverse transcription of the isolated RNA to DNA 
using a transcriptase enzyme and oligo-dT and random primers. The next step is 
the PCR amplification of the target gene using specific primers in a thermocycler. 
A fluorescent dye (e.g. SYBR Green in our study) is bound to the double-stranded 
DNA and is detected in real time. When the fluorescence intensity of the DNA 
product reaches the detection threshold, Ct value or threshold cycle is determined, 
which reflects the amount of the DNA template when the efficiency of the reaction 
is optimal (assessed by making a standard curve of serial dilutions of a cDNA 
sample). The DNA quantity of the sample is determined in comparison to the 
standard curve of the standard sample. The standard sample is ideally a sample 
with known quantity of the target gene or a sample estimated to have a substantial 
amount of the target gene. We used the latter, thus the values we obtained by this 
method are relative rather than absolute. A key step of the calculations is to nor-
malize the obtained value of gene expression to the expression of the reference 
gene which should not change in response to the stimuli. This way, the results are 
presented as target gene/reference gene ratio. In some conditions, finding a stable 
reference gene might be challenging. Therefore, it is important to use exactly the 
same amount of RNA from all samples in the cDNA synthesis step with several 
replicates. 
 
RT-qPCR is an extremely sensitive method for detection of a few copy numbers 
of DNA. Therefore, accurate pipetting of the reagents and samples in the tube is a 
crucial step. Moreover, a negative control sample containing the reagents only 
should be included to verify that the reagents are not contaminated with DNA. 
The melting temperature analysis is also another critical control step to ensure that 
obtained signal comes from a single PCR product specific to the target template.  
 
Flow cytometry 
 
The transcribed mRNA of genes does not always translate into a protein product 
due to post-transcriptional regulation of gene expression by, for example, interfer-
ing RNAs (RNAi). Therefore, it is important to also measure the protein expres-
sion and not just gene expression. Conventional methods such as Western blot and 
IHC are very reliable but have some limitations such as being semi-quantitative in 
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addition to limitation of number of targets that can be detected at the same time. 
Flow cytometry is a method for identification, characterization and quantification 
of cell phenotypes by detecting and measuring expression of different proteins 
labelled with fluorescent molecules (e.g. fluorescent antibodies) in single cells in 
a flow system. The advantage of this method is that the expression of several pro-
teins can be quantified simultaneously by using an array of antibodies tagged with 
different fluorochromes, which is particularly powerful when phenotyping cells. 
In paper I and III we performed flow cytometry to identify and characterize dif-
ferent immune cells in the brain. In paper I, the brain tissue was dissociated me-
chanically to obtain single cell suspension. In paper III, the enzymatic digestion 
of the brain preceded the mechanical dissociation in order to enhance the cell vi-
ability and integrity. White blood cells in blood and CSF were also analyzed by 
flow cytometry in Paper III. Prior to flow cytometry, red blood cells were lyzed 
by a hypertonic salt solution. After tissue dissociation and quantification of the 
single cells, non-specific binding sites were blocked and cells were incubated with 
primary and fluorescent secondary antibodies. For the CSF samples that do not 
contain numerous cells, the washing steps were minimized to avoid cell loss.  
 
The analysis of flow cytometry data is based on a gating strategy to distinguish 
and quantify different cell populations based on their characteristics. First, cells 
are gated based on the physical characteristics, their size and granularity. This 
information is obtained based on how the light is scattered by the cells straight 
forward or to the sides. Next, the cells are usually gated based on viability and 
singularity. This is followed by gating based on the expression of a lineage marker 
such as CD45 which is a surface protein expressed by all leukocytes. The gating 
continues based on other proteins expressed by specific cells in order to identify 
and quantify cell subtype specific populations. The results are presented as pro-
portion of subtypes of parent populations.  
 
Multiplex cytokine assay 
 
Multiplex cytokine assay is an immunoassay for simultaneous quantification of 
multiple target proteins in a sample. There is a significant advantage of this tech-
nique for small-volume samples such as CSF from rodents. In paper III and V, we 
used this method to measure several cytokines in plasma, CSF and the choroid 
plexus epithelial cell culture medium. In this method, magnetic microbeads (the 
size of a mammalian cells) labelled with a certain fluorophore is covalently bound 
to an antibody specific to a target molecule, e.g. a cytokine. The cytokine in the 
sample thus binds the corresponding antibody-coupled bead and the unbound pro-
teins are removed by washing. Then a biotinylated antibody targeting another 
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epitope of the cytokine is added followed by addition of fluorescent-tagged strep-
tavidin that binds biotin. By this technique, the final sandwich product emits two 
fluorescent lights, one coming from the bead identifying the target cytokine and 
the second originating from the bound antibody-biotin-streptavidin correlating to 
the amount of the cytokine. The fluorescent intensity is translated to a concentra-
tion by relating to the values on a standard curve. The detecting machine is also a 
flow cytometer (Bio-plex 200 System in our case). 
 
Magnetic activated cell sorting (MACS) 
 
In unpublished work related to Paper II, we isolated microglia cells from PND9 
mice by performing MACS. The method involves identifying target cell types in 
a suspension based on a cell surface marker using a specific antibody conjugated 
to magnetic beads. The cells then pass through the magnetic columns and the tar-
get cells are bound to the magnets and then eluted.   To make the cell suspension, 
brain tissue was enzymatically digested using 0.01% papain, 0.1% dispase, 0.01% 
DNase and 12.4mM MgSO4 in phosphate buffer saline (37°C for 10 min) followed 
by mechanical dissociation by triturating. For MACS isolation of microglia cells 
CD11b magnetic bead-conjugated antibody (Milteny) was used following the 
manufacturer protocol and using autoMACS Pro Separator (Milteny). Posseld2 
program was used in which the cells pass through two magnetic columns instead 
of one to enhance the purity. 
 
Western blot 
 
In another unpublished work related to paper II (Fig. 12), Western blot (WB) was 
performed on brain isolated mitochondria. Brain mitochondria isolation was per-
formed according to the previously described Method A in (Wang et al., 2011). 
WB is a gold standard immunoassay for detection and relative quantification of 
the target proteins. Isolated mitochondria were frozen and thawed followed by a 
brief sonication. The lysed mitochondria were mixed with Laemmli Sample buffer 
(containing 10% beta-Mercaptoethanol, Bio-Rad) and heated at 95°C for 5 min 
before being loaded to the 8–16% Criterion™ TGX™ Precast Protein Gel. The 
proteins were transferred to a PVDF membrane in a Trans Blot Turbo system (Bi-
orad). Following blocking in 5% milk for 1h RT, the membranes were incubated 
with primary antibodies against superoxide dismutase 2 (SOD2, abcam; 1:2000) 
or peroxiredoxin 3 (PRX3; abcam; 1:2000) overnight at 4°C. After incubation 
with corresponding secondary antibodies (Vector) visualization was performed 
using Clarity ECL substrate (Bio-Rad) in a ChemiDoc XRS+ System (Bio-Rad), 
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and total protein normalization was performed following the manufacturer’s pro-
tocol.  
 
Mitochondrial respirometry 
 
Mitochondria are the power plants of the cells, producing the majority of the cell 
high-energy phosphate molecule ATP through their electron transfer chain (ETC) 
and ATP synthase (Fig. 5) (West et al., 2011). The glycolysis (cytoplasm) and 
Krebs cycle are other cellular pathways producing small numbers of ATP mole-
cules. The glycolysis by-product pyruvate enters the mitochondria and through the 
Krebs cycle, the electron carrier molecules nicotinamide adenine dinucleotide 
(NADH) and flavin adenine dinucleotide (FADH2) are produced and can enter the 
ETC.  The ETC consists of four transmembrane enzyme complexes in the inner 
membrane (between the matrix and intermembrane space) of the mitochondria, of 
which three act as proton pumps as well.  NADH and FADH2 electrons are trans-
ferred to the complex I and complex II of the ETC respectively, and then via the 
complex II to complex III and complex IV, leading to H+ protons being pumped 
out of the membrane into the intermembrane space.  
 
The electrons are received back in the matrix via oxygen molecules and water 
molecules are formed. As the concentration of H+ protons increases, the gradient 
forces relay of the protons to complex V, the ATP synthase, and back to the matrix 
during which ATP is formed from ADP. This is called coupled respiration or ox-
idative phosphorylation. If the protons do not enter complex V to make ATP but 
Figure 5. Mitochondria elec-
tron transport chain. . Re-
printed by permission from 
Macmillan Publishers Ltd: 
[Nature Reviews Immunol-
ogy] (West et al., 2011). 
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just leak back to the matrix (e.g. in the absence of ADP) or transfer through un-
coupling proteins it is called leak or uncoupled respiration, respectively. Through-
out the mitochondrial respiration, ROS are also produced of which a proportion 
are neutralized by mitochondrial antioxidant enzymes such as superoxide dis-
mutase (SOD) (Fig. 5). 
 
Mitochondrial respiration is assessed by measuring the oxygen consumption in a 
closed chamber. We used a high-resolution low-noise respirometry system, O2K 
(Oroboros Instruments). In the respirometer, the oxygen amount is first obtained 
as a current voltage between a gold cathode and silver anode with potassium chlo-
ride as the electrolyte. The current is the result of the oxygen reduction at the cath-
ode. The voltage is then translated to O2 flux (pmol.s-1.ml-1). Each of the ETC 
enzyme complexes can be fed with their substrates, at saturating concentration, 
and O2 consumption can be measured in real-time, which is the main advantage 
of the O2K system, in addition to the highly sensitive low-noise O2 sensors. The 
respirometry can be performed on cells or isolated mitochondria. The advantage 
of respirometry on isolated mitochondria is that the respiration is not affected by 
other cellular factors, thus easier to interpret the mitochondrial function. There-
fore, we isolated mitochondria from the brain using an established method. The 
complex I substrates pyruvate and malate were added to the respirometer cham-
bers with mitochondria which leads to the leak or basal respiration. Addition of 
ADP rapidly stimulates oxidative phosphorylation and ATP synthesis. Adding the 
compound FCCP (Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) 
which permeabilizes the inner membrane to the H+ protons leads to breakage of 
the proton gradient and uncoupling of ETC from oxidative phosphorylation.  The 
O2 consumption rate was normalized to the protein content of the sample.  
 
Brain barriers permeability test 
 
The BBB and BCSFB are impermeable to peripheral molecules with certain phys-
ical and biochemical properties. In addition, efflux system at the barriers removes 
undesired molecules. This is a major obstacle in developing drugs that can pene-
trate into the CNS. Although it is generally believed that molecules larger than 
500 Da or/and low lipophilic are not passively diffused to the CSF, several excep-
tions makes this general assumption irresolute (Banks, 2009). We tested the brain 
barriers permeability to 14C sucrose, a passive permeability marker, with molecu-
lar weight of 340 Da. In paper III, the samples were collected 30 minutes after 
sucrose i.p. injection and the plasma/brain tissue or plasma/CSF ratio of radioac-
tivity was obtained as permeability values for BBB and BCSFB respectively. The 
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brain tissue concentrations were corrected for blood residual which is estimated 
to be ~1% of brain volume (Gregoriadis, 1993). In paper V, first a concentration-
time curve was obtained by collecting plasma 3-30 minutes after 14C sucrose i.p. 
injection and measuring the radioactivity in samples.  
 
 
The area under the curve (AUC) was used to calculate the 14C sucrose CSF influx 
constant as:  
 
K in csf = Ct/AUC0→t 
 
The Ct is the sucrose concentration in the CSF at sampling time and AUC0→t is the 
14C sucrose concentration in the plasma from time zero to the CSF sampling time.  
 
Cre-recombinase mediated gene targeting in the 
choroid plexus 
 
Cre recombinase/loxP system has been widely used for tissue-specific knock out 
of genes in laboratory animals. Cre recombinase is an enzyme that was first dis-
covered in P1 bacteriophages with a function of catalysing the DNA recombina-
tion at the recognitions sites of loxP (Nagy, 2000). Cre recombinase/loxP system 
in mice involves a mouse that expresses Cre and a mouse that has loxP sites flank-
ing a specific gene. The Cre gene is transgenically inserted into the mouse genome 
and replaces a gene which is specifically expressed in a tissue of interest. The loxP 
sequence is inserted on the sides of a target gene. Breeding the Cre mouse to loxP 
mouse for several generations leads to excision of the target gene in that specific 
tissue. Since the choroid plexus is an epithelial tissue which is abundant in the 
body, it is challenging to specifically target the choroid plexus using Cre/loxP 
system as described. A solution would be to expose the target cells directly to the 
Cre recombinase. However, cells are not permeable to the Cre enzyme. To over-
come this challenge, a study described how Cre can be fused to the HIV protein 
Tat (Cre-Tat) to enhance the cell penetration (Wadia et al., 2004). To target the 
Figure 6. Intracerebroventricular injection 
sites on a P3 mouse. Left panel the injection 
site coordinates; right panel the coronal 
cut of the brain after the dye injection. 
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choroid plexus cells, we injected Cre-Tat directly into the ventricles to access the 
epithelial cells of choroid plexus as described by (Spatazza et al., 2013) in the 
adult mouse. We modified the method for P3 pups. The coordinates of the intrac-
erebroventricular (ICV) injection sites was determined after several test injections 
of a dye, Evans blue (Fig. 6). The Cre-Tat dosage was also determined in pilot 
experiments based on the manufacturer data from in vitro tests. 
 
RNA sequencing 
 
RNA sequencing ( RNA seq) is known as a “revolutionary tool” that has trans-
formed the biomedical science in the past decade by revealing the whole transcrip-
tome of cells in health and diseases and in different animal species (Wang et al., 
2009b). RNA seq has some advantages over older transcriptomic tools such as 
microarray. The microarray transcriptomic techniques are limited to known tran-
scripts of genes, while with RNA seq it is possible to discover new gene transcripts 
or novel spliced forms. High sensitivity for detection of low number of transcripts 
and great reproducibility are other advantages of RNA seq (Wang et al., 2009b). 
Using this method, different species of RNA (e.g. mRNA, miRNA) can be se-
quenced and quantified. In Paper IV, we performed RNA seq on an Illumina plat-
form. In our study, the RNA was extracted from the choroid plexus and the 
quantity and quality of the RNA was assessed using a Bioanalyser system. In this 
system, RNA is electrophoretically separated on a microfabricated chip. All RNA 
bands, including the ribosomal RNA (18S and 28S) are automatically analyzed 
(Fig. 7) and a RNA integrity number is obtained (RIN score, scale of 0-10). The 
average RIN score of the samples in our study was 9.2, suggesting a high quality 
of RNA.  
 
Figure 7. RNA quality as-
sessment by Bioanalyser sys-
tem on samples in paper V. 
RNA bands on electrohoretic 
gel (right panel) are ana-
lyzed by the system. The 
large peaks represent bands 
corresponding to 18S and 
28S ribosomal RNA (left 
panel). 
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The sample preparation included removal of ribosomal RNA, fragmentation and 
cDNA synthesis. During removal of ribosomal RNA, small RNAs were also de-
pleted leaving mRNAs and long non-coding RNAs. We omitted small RNAs since 
a different sample preparation was required and the RNA quantity was not suffi-
cient.  We aimed for 30 million reads per sample which is sufficient for differential 
expression analysis (Conesa et al., 2016). The length of the read was 100 base pair 
and was performed in a paired-end manner. The length of the read is important 
since very short reads cannot be mapped with certainty and are discarded. The 
read length of 100 base pairs is appropriate for accurate mapping as well as for 
detection of the splice junctions  (Chhangawala et al., 2015). In paired-end se-
quencing, a DNA fragment is read from both ends in opposite directions, while in 
single-end sequencing the read is done in one direction. The former enhances the 
accuracy of the transcript mapping on a chromosome and identification of the 
splicing isoforms (Katz et al., 2010).  
 
Transcriptome analysis 
 
RNA seq produces a significant amount of data for analysis. Some experimental 
or clinical conditions change the transcription of thousands of genes. Therefore, 
the analysis and interpretation of this bulk of data requires the use of sophisticated 
mathematical models and analysis software. In paper V we compared the tran-
scriptome of choroid plexus in five conditions including control samples. The 
count number of reads of a transcript is obtained from the sequencer. The basic 
analysis is differential expression analysis that demonstrates which genes are sig-
nificantly regulated by conditions and how large is the difference (i.e. fold 
change). Following this, a gene clustering analysis can be performed where the 
aim is to find groups of genes that have similar expression patterns. This is per-
Figure 8. The clustering of genes ex-
pressed in two experimental conditions. 
Each dot represents a gene and x and y 
axis represent their expression level. The 
genes with shorter distance from each 
other cluster together. A heatmap (right 
panel) is made based on the clusters. 
Adapted by permission from Macmillan 
Publishers Ltd: [Nature biotechnology] 
(D'Haeseleer, 2005) 
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formed by calculating the mathematical distance between them. As shown in fig-
ure 8, the genes that are closer together form a cluster (D'Haeseleer, 2005). 
Then, these groups of genes with similar expression patterns can be further ana-
lyzed by functionally annotating the gene clusters. This is performed by GO on-
tology profiling of genes. In the GO ontology database, each gene has been 
assigned a GO term (e.g. a biological pathway/function such as apoptosis) based 
on the knowledge or predictive methods (Yon Rhee et al., 2008). By mathemati-
cally comparing the number of significantly regulated genes that are related to a 
GO term in a dataset (e.g. 4 out of 1000 genes related to X term in our dataset) 
with all genes related to that GO term in a species (e.g. 500 out of 2300 mouse 
genes related to X term), an enrichment score and a significance value is obtained. 
We used DAVID Functional Annotation Tool v 6.8 for this purpose (Huang da et 
al., 2009b, a).  
 
The GO ontology is a useful tool to gain an overall biological interpretation about 
the regulated genes in a dataset. However, this tool does not take into account the 
interactions between various gene products in a biological system and direction-
ality of these interactions. Therefore, we used the Ingenuity Pathway Analysis 
(IPA) which is a knowledge-based platform for analysis of omics data. The IPA 
knowledge database is constructed and continuously updated by curators, which 
extract all the information about the interactions between biological molecules 
from research studies and their relationship to biological pathways and functions. 
Based on this database and mathematical models, IPA predicts what biological 
pathways are regulated (up or down) by the gene changes in the dataset. Moreover, 
upstream or downstream regulators of pathways are also predicted.  
 
In vitro model of neutrophil transmigration through 
choroid plexus 
 
Modelling choroid plexus in vitro has been a challenge for several reasons:   
 
- choroid plexus consists of various cell types and a stroma 
- choroid plexus is a highly polarized tissue 
- choroid plexus epithelial cell barrier function should be mimicked 
- choroid plexus of rodents such as mouse and rat is a small tissue, which 
means several animals need to be sacrificed for an  in vitro experiment 
 
The current choroid plexus in vitro models include a monolayer of epithelial cells 
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(choroid plexus epithelial cells; CPEC), the principal cell component of the cho-
roid plexus tissue. To date, there is no co-culture model of choroid plexus epithe-
lial and endothelial cells that comprises the choroid plexus vessels. However, most 
other properties of the choroid plexus can be recapitulated in vitro. For CPEC 
culture, both primary and immortalized cells have been used. However, the im-
mortalized cell lines fail to reproduce some critical functions and characteristics 
of the choroid plexus such as the barrier function (Kläs et al., 2010; Lazarevic and 
Engelhardt, 2016). Therefore, in Paper V we used a method of primary culture of 
neonatal rat CPEC which was first described by  (Tsutsumi et al., 1989) and later 
was optimized by (Strazielle and Ghersi-Egea, 1999). In this method, the choroid 
plexus tissue is first enzymatically and mechanically dissociated and then the ep-
ithelial cells are separated by sedimentation and differential adhesion to a plastic 
surface. The isolated cells are grown for approximately one week on a filter coated 
with extracellular matrix protein, laminin. For leukocyte trafficking studies the 
filter insert is inverted and cells are seeded before placing it back to its position in 
the well (Fig. 9). Before the transmigration experiment, the effect of different dos-
ages of P3C on the CPEC permeability was assessed to insure the integrity of the 
barrier. 
 
 
We isolated leukocytes from neonatal rat blood after hypertonic lysis of red blood 
cells. The leukocytes were added to the basal side of the choroid plexus and were 
allowed to transmigrate for five hours. The transmigrated cells were then collected 
from the apical side by centrifuging the medium and the cells were counted in a 
Bürker chamber or fixed on a slide for immunocytochemistry.  
 
Statistics 
In general, we used Student's t-test when comparing two groups of samples and  
one-way analysis of variance (ANOVA) together with a post-hoc test when com-
paring multiple groups. The significance was set at p<0.05.  These tests are based 
on the assumption that the sample populations follow a Gaussian distribution. 
Figure 9.  Inverted and non-
inverted model of choroid 
plexus epithelial cell culture 
on the filter insert. 
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However, the tests perform well even if the distribution is not ideally normal es-
pecially for large sample size (Lumley et al., 2002). Therefore, we did not test for 
normal distribution. The sample size for the HI experiments was fairly large and 
based on our previous studies and understanding of the injury variability. The data 
are presented as mean ± SEM or mean ± SD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38   R ESULTS SUM M AR Y  
 
Results summary 
Systemic activation of viral (TLR3) or bacterial 
(TLR2) receptors aggravates HI brain injury in ne-
onatal mice 
 
Infection and inflammation in the perinatal period is a major risk factor for brain 
injury in newborns (Hagberg et al., 2015). Our group previously showed for the 
first time that systemic activation of TLR4, a receptor for bacterial LPS, worsens 
the HI injury in the neonatal rats (Eklind et al., 2001). TLR4 is the main immune 
receptor for gram-negative bacteria. However, a large proportion of perinatal in-
fections are caused by gram-positive bacteria and mycoplasma (Tita and Andrews, 
2010) for which TLR2 plays a key role in recognition and in the inflammatory 
response (Takeuchi et al., 1999). Moreover, viral infections are another cause of 
inflammation in the perinatal period (Silasi et al., 2015) with TLR3 being critical 
for initiating the response. Therefore, we asked whether systemic activation of 
these immune receptors impacts on the HI brain injury. We used a neonatal mouse 
model of HI at an age corresponding to brain development in near term infants. 
Poly I:C and P3C were used as agonists for TLR3 and TLR2 respectively. Sys-
temic administration of TLR3 and TLR2 agonists 14h prior to HI increased the 
neuronal tissue (MAP2+ tissue loss) loss by 91% (Paper I) and 46% (Paper II) 
respectively compared to the control group which received saline. Moreover, 
TLR3 stimulation increased the white matter (MBP+ tissue loss) injury at hippo-
campal and striatal levels by 430% and 140% respectively (Paper I). TLR2 acti-
vation also increased the total subcortical white matter injury by 32% (Paper II). 
Neonatal mice lacking the TLR3 adapter molecules TRIF were protected against 
the sensitizing effect of PolyI:C (Paper I). Likewise, TLR2 knockout mice were 
protected against the sensitizing effect of P3C (Paper II). 
 
We also asked whether specific regions of the brain were more vulnerable to P3C-
sensitized HI injury. Neuropathology scoring did not show a regional specificity 
of P3C sensitization (Fig. 10A). However, TLR2 knock out mice were most pro-
tected in the cerebral cortex (Fig. 10B).  
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TLR3 activation induces neuroinflammation 
 
Next, we asked whether systemic TLR3 activation leads to CNS inflammation. 
We assessed the CNS inflammation induced by Poly I:C by RT-qPCR (Paper I). 
Poly I:C significantly upregulated mRNA expression of IL6, TNF-a, IP10, IFN-b 
and MCP1 at 6h time point compared to the control group. At 14h, TNF-a, IL1-a, 
IFN-b and MCP1 were significantly upregulated (Paper I). The neuroinflamma-
tory effect of PolyI:C was TRIF dependent as PolyI:C had no neuroinflammatory 
effect in TRIF KO mice (Paper I).  
 
TLR3 activation suppresses cell survival pathways 
in the brain 
 
Quantification of mRNA expression of Fas ligand, a pro-apoptotic protein, 
showed a significant upregulation by PolyI:C compared to the control. Further-
more, the phosphorylation of Akt, a pro-survival signaling molecule was signifi-
cantly reduced by PolyI:C treatment (Paper I). 
 
 
 
Figure 10. TLR2 activation homogenously sensitizes all the brain regions to HI (A), 
however, TLR2 knockout mice are most protected in the cerebral cortex (B). Data 
presented as mean ± SEM. *P<0.05, **p<0.01, One-way ANOVA, n= (see Paper 
II). 
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TLR3 and TLR2 stimulation alter the microglia 
phenotype 
 
Microglia cells are the most abundant professional immune cells in the brain pa-
renchyma, and develop different phenotypes in response to stimuli including a 
M1-like pro-inflammatory and M2-like reparative phenotype. Therefore, we 
asked whether TLR stimulation alters the microglia phenotype using flow cytom-
etry on the brain single cell suspension (Paper I) and qPCR on isolated microglia. 
Poly I:C reduced the proportion of microglia with a reparative M2 phenotype. 
Likewise, neonatal mice treated with Poly I:C and exposed to HI had a signifi-
cantly lower number of M2 microglia cells in the contralateral hemisphere com-
pared to control group. In the ipsilateral hemisphere Poly I:C+HI mice also had a 
lower number of M2 microglia than saline+HI mice, although the difference was 
not statistically significant (Paper I). 
 
On the other hand, microglia cells isolated from brain by magnetic-activated cell 
sorting at 14h after P3C treatment showed a mixed inflammatory phenotype char-
acterized by upregulation of mRNA expression of both pro-inflammatory cyto-
kines (e.g. IL1a, IL1b, TNFa ) and anti-inflammatory cytokines (e.g. IL10) (data 
not shown). 
 
Moreover, the number of microglia cells increased after HI in the ipsilateral hem-
isphere, however, prior PolyI:C (Paper I) or P3C (Fig. 11A) treatment did not af-
fect the microgliosis. TLR2 deficiency also had no effect on microgliosis after 
P3C/saline+HI (Fig. 11B). 
 
Figure 11. Number of Iba-1+ microglia cells increase in ipsilateral hemisphere after HI. 
Microgliosis is not affected by prior P3C treatment (A) or TLR2 deficiency (B). ). Data 
presented as mean ± SEM. *P<0.05, **p<0.01, ****p<0.0001, One-way ANOVA, n= (see 
in Paper II).  
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Systemic TLR2 activation suppresses brain mito-
chondrial respiration 
 
HI brain injury is primarily induced by general energy failure. Therefore, we asked 
whether systemic inflammation alters the function of the cellular powerhouse, the 
mitochondrion. We used a high-resolution respirometry system to assess respira-
tion of mitochondria isolated from the brain 14h after systemic administration of 
P3C or saline. Oxidative phosphorylation induced by ADP was significantly sup-
pressed by 23% in the P3C group compared to the saline group. Moreover, uncou-
pled respiration induced by FCCP showed a 21% reduction in the P3C group 
although the difference was not statistically significant (paper II). 
 
We also asked whether P3C-induced systemic inflammation induces a mitochon-
drial oxidative stress and change in mitochondrial antioxidant enzymes. There-
fore, we performed western blotting to measure the amount of SOD2 and PRX3 
from brain-isolated mitochondria 14h after P3C or saline administration. We did 
not observe any significant change between P3C and control group (Fig. 12).  
 
 
 
 
Figure 12. P3C does not change the protein expression of mitochondrial antioxidant en-
zymes SOD2 and PRX3 analyzed 14h after treatment. Representative image of western 
blotting for SOD2 and PRX3 (left) and the band analysis (right). Data presented as 
mean±SEM, n=8. No significant difference was observed between groups as assessed by 
Student t-test. 
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Systemic activation of TLR2 but not TLR4 induces 
neutrophil and monocyte invasion of the CNS 
 
TLR2 and TLR4 are both receptors that are activated by certain bacteria and acti-
vation of either leads to phosphorylation and nuclear translocation of transcription 
factor NF-κB and expression of inflammatory cytokines. Surprisingly, i.p. injec-
tion of P3C (TLR2 agonist) but not LPS (TLR4) induced massive leukocyte infil-
tration to the CSF of neonatal and adult mice (Paper III). Likewise, P3C injection 
in neonatal rats caused a similar effect (Paper V). Infiltrating leukocytes were de-
tected in the CSF as early as 6h after the P3C administration and peaked at 14h in 
neonatal mice. The number of cells gradually decreased at 24h and 48h time points 
(Paper III). Two dosages of P3C (1 mg/kg and 5 mg/kg) had similar effect. At the 
48h time point, LPS injected at 1mg/kg (but not 0.3 mg/kg) slightly increased the 
number of leukocytes in the CSF. Flow cytometry revealed that the P3C-induced 
CSF-infiltrating leukocytes in neonatal mice were mainly neutrophils at 6h and 
inflammatory monocytes at 14h and 24h time points (Paper III). However, in ne-
onatal rats infiltrating leukocytes were mainly neutrophils at 14h, as assessed by 
immunocytochemistry (Paper V). 
 
To understand the striking difference between P3C and LPS, we first hypothesized 
that P3C at the administered dosages induced a stronger inflammatory response 
than LPS. We measured 23 cytokines in the plasma and spleen and found that LPS 
at either high or low dosage induced higher or similar level of cytokines as P3C 
6h after injection. Therefore, we asked if P3C induces a specific neuroinflamma-
tory profile. Multiplex cytokine assay showed significant release of IL1a, IL12, 
KC, MCP1, MIP1a, MIP1b and G-CSF in the brain 6h after administration of 5 
mg/kg P3C. High dose LPS, on the other hand, induced significant release of G-
CSF, IL6, KC, MCP1 and RANTES in the brain, while cytokine induction by low 
dose LPS was not significantly regulated (Paper III).  
 
Next, we asked if P3C administration changed the CNS barrier permeability. To 
achieve this, we injected 14C-sucrose intraperitoneally following P3C treatment 
and measured the accumulation rates of sucrose from blood to different CNS com-
partments including the CSF to assess changes in CNS barrier permeability. P3C 
increased the permeability of both the BBB and BCSFB 10h after administration 
(Paper III). The effect of P3C on BSCFB permeability was also tested and repro-
duced in neonatal rats (Paper V). 
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Choroid plexus is a route of TLR2-induced leuko-
cytes trafficking 
Next, we asked where in the brain the infiltrating leukocytes localize. To address 
this question, we first performed flow cytometry and found that in P3C-injected 
neonatal mice there were significantly higher numbers of CD11b+CD45hi infil-
trating leukocytes (Paper III). Then, we performed immunohistochemistry using 
LysM-EGFP mice in which peripheral myeloid cells express GFP. The results 
showed that infiltrating neutrophils and monocytes localize in periventricular re-
gions of the brain including the choroid plexus and median eminence as well as in 
the subarachnoid space (Paper III). Therefore, we hypothesized that choroid 
plexus is a route of leukocyte entry. We tested this hypothesis in vivo and in vitro: 
 
We first asked whether knocking down TLR2 adapter molecule MyD88 specifi-
cally in choroid plexus would inhibit the P3C-induced leukocyte infiltration to the 
CSF. To address this question, we injected Cre-Tat or saline intracerebroventric-
ularly to P3 MyD88-flox mice. In response to P3C injection at P8, mice that had 
received Cre-TAT demonstrated 59% reduction in the number of infiltrated leu-
kocytes in the CSF compared to the mice that received saline (Paper V).  
 
To investigate whether leukocytes can transmigrate through the choroid plexus we 
performed studies in vitro. Leukocytes were isolated from neonatal rats after P3C 
injection and were added to the monolayer of CPEC pre-treated with P3C or sa-
line. Neutrophils could transmigrate through the CPEC pre-treated with P3C but 
not saline (Paper V). Altogether, the results showed that the choroid plexus is a 
route of leukocyte entry after P3C administration.  
 
TLR2 induces specific chemotaxis and cytoskele-
ton regulating pathways in the choroid plexus 
 
To understand the mechanism of leukocyte transmigration through choroid plexus 
we performed RNA sequencing on choroid plexus isolated from mice 6h and 14h 
after injection with P3C or LPS. We hypothesized that both P3C and LPS induce 
an inflammatory response in the choroid plexus; however, genes that are specifi-
cally induced by P3C might be responsible for regulating the leukocyte transmi-
gration. We selected the dosages of LPS and P3C that induced a similar systemic 
inflammatory response (Paper II). 
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Differential expression analysis of RNA seq data revealed that both P3C and LPS 
significantly regulated expression of thousands of genes in the choroid plexus 
(Fig. 13, paper IV). The number of genes regulated by LPS was higher than by 
P3C at both time points. There were 832 and 241 genes specifically regulated by 
P3C at 6h and 14h, respectively (Fig. 13). Gene cluster analysis and Ingenuity 
Pathway Analysis revealed P3C-specific effects on chemotaxis and cytoskeleton-
regulating pathways (Paper IV). 
 
 
 
 
 
 
N-acetyl cysteine blocks TLR2-mediated leuko-
cyte infiltration to the brain 
Reactive oxygen species (ROS) have a profound role in immune response as well 
as in cytoskeleton remodeling (Staiculescu et al., 2014). We asked whether target-
ing ROS has an impact on TLR2-mediated leukocyte migration to the CSF. We 
used N-acetyl cysteine (NAC) to target ROS as it has previously been shown to 
be effective in neonatal LPS-induced inflammation (Wang Ann Neurol 2007). 
NAC treatment almost completely blocked leukocyte infiltration to the CSF in 
neonatal rats treated with P3C (Paper V). Likewise, NAC treatment of CPEC sig-
nificantly diminished P3C-mediated neutrophil transmigration. Multiplex cyto-
kine assay revealed that the effect of NAC was largely independent of peripheral 
and central cytokine induction (Paper V). 
 
Figure 13. A Venn diagram showing 
the number and percentage of genes 
significantly regulated by P3C or LPS 
in the choroid plexus at different 
times after treatment. 
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Discussion 
Sensitization of the developing brain to HI by sys-
temic inflammation 
Infection and inflammation are known risk factors for human neonatal brain in-
jury. Previous experimental studies also support a contributory role of inflamma-
tion in neonatal HI injury (Hagberg et al., 2012; Hagberg et al., 2015).  These 
studies have also shown that the inflammation-induced sensitization of the devel-
oping brain to the injury is time-dependent and dose-dependent. In other words, 
the effect of the inflammation on the brain injury depends on the temporal stage 
of the inflammation and its magnitude. For example, when LPS is injected 4h, 6h, 
or 72h before HI in neonatal rats the brain injury is increased (Eklind et al., 2001; 
Eklind et al., 2005). Likewise, LPS injection 14h before HI on P9 mice exacer-
bated the brain injury (Wang et al., 2009a). However, LPS injection 24h before 
HI leads to a pre-conditioning effect and reduced the injury (Eklind et al., 2005).  
Furthermore, low dose LPS injected 24h before HI reduces the neuroinflammation 
and protects the neonatal rat brain while high dose did not (Lin et al., 2009).  The 
preconditioning is a general effect following a subtle insult that protects against a 
major insult. For example, a period of hypoxia 24h before the HI protects the brain 
of neonatal rats and improve the long-term outcome of sensory and cognitive func-
tions (Gustavsson et al., 2005). The mechanism of the LPS preconditioning is yet 
to be elucidated; however, some components of cell death/survival pathways such 
as Bcl-2 family, JNK pathway, trophic factor pathways and inositol triphosphate 
kinase/Akt pathway has been suggested to be involved (Gustavsson et al., 2007; 
Mallard and Hagberg, 2007).  
Overall, previous experimental studies suggest that inflammation with sufficient 
strength during an acute phase can sensitize the brain to HI injury. However, less 
is known about how different inflammatory stimuli sensitize to HI injury. As men-
tioned, the effect of the TLR4 agonist LPS on neonatal HI brain injury has been 
studied. LPS is the major component of the cell wall of gram-negative bacteria. 
However, gram-positive bacterial infections and viral infections are other im-
portant causes of perinatal inflammation that stimulate an inflammatory response 
via TLR2 and TLR3 respectively. In the present thesis we demonstrated that sys-
temic activation of either TLR3 (Paper I) or TLR2 (Paper II) exacerbated the HI 
brain injury both in the grey and white matter.  
While preparing this thesis a study was published by (Falck et al., 2017) showing 
that systemic activation of TLR2 in neonatal rats also sensitize the brain to HI 
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injury. Interestingly, the authors found that hypothermia was neuroprotective in 
P3C+HI model while it had no effect on the LPS+HI model suggesting a patho-
gen-dependent mechanism of injury and protection.  
 
How does systemic inflammation sensitize the 
brain to HI injury? 
We showed that systemic activation of TLR3 and TLR2 sensitizes the developing 
brain to HI injury. Both grey matter and white matter were affected. The grey 
matter tissue loss is the result of neural cell death. White matter loss was examined 
by loss of area of MBP staining. This may reflect white matter injury due to dam-
age of the myelin sheath, axons and/or the oligodendrocytes (Hagberg et al., 
2002a; Back and Rosenberg, 2014). In the present thesis detailed anatomical 
changes of the brain injury were not examined. However, potential mechanisms 
that may be involved in the injury progression was examined by addressing mainly 
three aspects: 
1. TLR-mediated neuroinflammation 
 
We found that both systemic TLR3 and TLR2 stimulation caused inflammation in 
the brain represented by expression of various inflammatory cytokines and chem-
okines, although, the neuroinflammatory profile was highly different between the 
two TLR agonists. PolyI:C induced interferon-related genes as well as genes reg-
ulated by NF-κB transcription factor such as IL1b. On the other hand, P3C induced 
release of several cytokines and chemokines in the brain leading to the CNS leu-
kocyte invasion. One way to investigate experimentally whether these inflamma-
tory changes in the brain are essential for sensitization, is to block the 
communication of systemic inflammation to the brain. We did found that inhibit-
ing MyD88 activity in the choroid plexus ameliorated the P3C-induced neuroin-
flammation, however, the effect on HI injury remains to be investigated. Likewise, 
in paper V, we showed that targeting ROS activity by NAC reduced the neuroin-
flammation induced by P3C. However, we did not assess the effect of NAC on the 
HI injury. 
  
What factors other than neuroinflammation may underlie the sensitization effect? 
One possible mechanism could be inflammation-induced effects on the cerebral 
blood flow. However, a previous study did not find that LPS affects the cerebral 
blood flow in an LPS+HI model in neonatal rats (Eklind et al., 2001). Another 
possible mechanism might be the changes in body temperature induced by sys-
temic inflammation, since hyperthermia is associated with activation of apoptotic 
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pathways in the developing brain (Khan and Brown, 2002) and  increased brain 
injury in adult stroke (Ginsberg and Busto, 1998). Conversely, hypothermia is 
neuroprotective in human neonates with HIE and animal models (Davidson et al., 
2015). The neuroprotective effect of hypothermia might also affect neuroinflam-
mation. However, P3C administration did not change the rectal temperature dur-
ing HI, ruling out the possibility of hyperthermia-induced sensitization (Paper II). 
This is in agreement with the study by Falck et al where P3C had no effect on 
neonatal rat rectal temperature, however, hypothermia protected against the sen-
sitized brain injury. Other systemic effects of inflammation on lung, kidney and 
liver function might also affect circulation metabolites, nutrients and gases that 
can play a role in sensitizing HI injury. However, it can still be assumed that neu-
roinflammation is the key component.  
 
2. Neuroinflammation and cell death pathways 
 
Does neuroinflammation sensitize neurons to injury? First, it should be considered 
that microglia and astrocytes play key roles in inducing a neurotoxic inflammatory 
milieu. We found a switch in microglia phenotype by PolyI:C and P3C. It was 
recently discovered that microglia release of TNF, IL1a and C1q induces a neuro-
toxic phenotype of astrocyte (called A1), although the secreted neurotoxin by A1 
astrocytes remain to be identified. (Liddelow et al., 2017). In our study, PolyI:C 
induced TNFa mRNA upregulation in the brain. P3C, on the other hand, increased 
the mRNA expression of both TNFa and IL1a in the microglia and IL1a protein 
in the whole brain. Therefore, it is plausible that the neuroinflammation-induced 
sensitization might be partly due to microglia-dependent induction of A1 astro-
cytes. In support, it has been shown that microglia are required for LPS-induced 
oligodendrocyte injury and hypomyelination in the developing rat brain (Lehnardt 
et al., 2002). In addition to aforementioned hypothesis, neuroinflammation might 
directly affect the cell death pathways.   Generally, cell death occurs through three 
major mechanisms: necrosis, apoptosis and autophagy. The necrotic and apoptotic 
pathways have some overlaps during HI leading to a “continuum” form of cell 
death (Northington et al., 2011a). Necrosis was previously considered as a non-
programmed accidental cell death mechanism. However, recent advances revealed 
several regulated forms of necrosis including necroptosis, ferroptosis and parthan-
atos (Conrad et al., 2016). Necroptosis and parthanatos has been implicated in 
neonatal HI injury (Hagberg et al., 2004; Chavez-Valdez et al., 2012). Inhibiting 
necroptosis pathway by necrostatin reduced neuroinflammation and protected ne-
onatal mice against HI brain injury (Northington et al., 2011b). Necroptosis is in-
duced by TNF, FAS ligand, TNF-related apoptosis-inducing ligand (TRAIL) as 
well as TLR3 and TLR4 ligands (Weinlich et al., 2017). We showed that PolyI:C 
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upregulated the Fas ligand and TNFa expression in the brain (Paper I). P3C also 
upregulated the expression of TNF mRNA in the choroid plexus, however, it did 
not significantly change the TNFa protein in the brain. Therefore, there might be 
a link between TLR3 and TLR2 activation and the necroptosis pathway.   
 
Parthanatos is a caspase-independent mechanism of cell death mediated by poly 
(ADP-ribose)-polymerase (PARP) and involving mitochondrial protein AIF (Fa-
tokun et al., 2014). Interestingly, in EAE mice a cholesterol derivative activates 
PARP1 in microglia and astrocytes in a TLR2-dependent manner suggesting a link 
between these signaling pathways (Farez et al., 2009). Therefore, TLR2 activation 
affecting parthanatos in the neonatal brain might be plausible and warrants further 
investigation. 
 
Both TNF and Fas can also trigger apoptosis. Triggering apoptosis by these death 
receptor ligands as well as by excitotoxicity leads to oligomerization of BAK and 
BAX mitochondrial proteins which mediates permeabilization of mitochondria 
outer membrane, release of cytochrome c to the cytosol, formation of apoptosome 
and activation of the executioner caspases (Fuchs and Steller, 2015). Inhibition of 
Bax activity by intracerebroventricular injection of a Bax-inhibiting peptide is 
neuroprotective in neonatal mouse HI (Wang et al., 2010). Therefore, mitochon-
dria plays a central role in HI brain injury (Hagberg et al., 2014). TLR3 activation 
has been associated with apoptosis mediated via death receptors and mitochondria 
in an endothelial cell line (Sun et al., 2011). Likewise, intrathecal administration 
of P3C is also associated with neural apoptosis that is mediated by microglia cells 
(Hoffmann et al., 2007). Therefore, apoptosis priming might be one of the sensi-
tizing mechanisms of PolyI:C and P3C. In support, we showed that PolyI:C inhib-
its the activation of anti-apoptotic kinase Akt (Paper I). In addition, PolyI:C 
activated NF-κB signaling (Paper I) that might in turn induce the pro-apoptotic 
p53 signaling (Fleiss et al., 2015). We also showed mitochondrial dysfunction by 
P3C in paper II which might prime the HI-induced apoptosis. As it is shown in 
some conditions, mitochondrial dysfunction precedes apoptosis probably via in-
duction of ROS (Green and Leeuwenburgh, 2002; Griffiths et al., 2008; Zanotto-
Filho et al., 2011). Moreover, reduction in mitochondrial respiration in cancer 
cells is associated with increased apoptosis mediated by ROS (Pelicano et al., 
2003; Kwong et al., 2007). We did not measure ROS induction in the brain after 
TLR3 or TLR2 stimulation, and assessment of brain mitochondrial antioxidant 
enzymes did not show any changes in response to P3C administration which may 
or may not reflect the oxidative status of the brain. Finally, it is known that HI-
induced excitotoxicity is enhanced by prior IL1b exposure (Degos et al., 2013). 
The expression of this cytokine was significantly upregulated by PolyI:C in the 
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brain and by P3C in the choroid plexus (Paper I and II) suggesting another mech-
anism of sensitization. 
 
Autophagy is a cellular intrinsic mechanism for homeostasis by which undesired 
macromolecules and organelles undergo lysosomal degradation. Whether autoph-
agy is a mechanism or a sequela (or both) of cell death has been a matter of debate 
in the last few years. However, growing evidence support the hypothesis of au-
tophagy as a cell death mechanism (Kroemer and Levine, 2008). Autophagy has 
been detected in dying thalamic neurons of asphyxiated newborns (Ginet et al., 
2014). In adult ischemic brain, however, autophagy has been suggested as a neu-
roprotective mechanism (Papadakis et al., 2013). Autophagy also plays a key role 
in inflammation and immunity (Levine et al., 2011). Although, we did not inves-
tigate the effect of TLR3 and TLR2 activation on brain autophagy-related pro-
teins, there is evidenc for a link between TLR signaling and autophagy (Shi and 
Kehrl, 2008). Altogether, neuroinflammation might prime cell death pathways 
leading to sensitization of the brain to HI. 
 
3. Neuroinflammation and cerebral energy metabolism 
 
HI is essentially an energy failure condition. The energy failure occurs in two 
phases. During the primary insult a transient reduction in cerebral blood flow 
causes primary energy failure and is followed by a latent phase where metabolism 
recovers, as assessed by measurement of high-energy phosphates by  magnetic 
resonance spectroscopy in asphyxiated human newborns (Hope et al., 1984) and 
piglets (Lorek et al., 1994). The latent phase is followed by secondary energy fail-
ure, the mechanism of which is not fully understood; however, excitotoxicity, mi-
tochondrial dysfunction, inflammation and oxidative stress have been implicated 
(Allen and Brandon, 2011; Hagberg et al., 2014). In paper II we showed that sys-
temic activation of TLR2 impairs complex-I mediated mitochondrial respiration. 
The respirometry was performed on mitochondria isolated from the brain, at the 
time when HI would have been induced. In other words, our results suggest that 
mitochondria are already dysfunctional at the time of primary energy failure. 
Therefore, TLR2 activation might have an accumulative effect on the HI-induced 
primary energy failure. Moreover, TLR-2 mediated mitochondrial dysfunction 
might potentiate the secondary energy failure as well. These hypotheses could be 
tested by measuring e.g. ATP at several time points after P3C/saline+HI. Further-
more, we did not investigate the underlying cause of mitochondria dysfunction, 
nor did we test the respiratory function of other complexes in the ETC. The enzy-
matic activity measurement of different ETC complexes would be a complemen-
tary experiment to elucidate the mitochondrial status change by systemic TLR2 
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activation. Several studies have shown a link between systemic inflammatory con-
ditions such as sepsis and mitochondrial dysfunction in the brain (Brealey et al., 
2002; d'Avila et al., 2008; Jeger et al., 2013) supporting a potential link between 
inflammation, mitochondrial function and HI injury.  
 
 
TLR2-mediated leukocyte trafficking to the CNS 
through choroid plexus 
We showed that systemic administration of the TLR2 ligand P3C induces marked 
infiltration of neutrophils and monocytes into the CNS. By performing several in 
vivo and in vitro experiments in two animal species, we found that choroid plexus 
is the most likely route of leukocyte entry into the CNS. Here I discuss some as-
pects of these results: 
1- What is special about TLR1/2 signalling? 
We found that systemic activation of TLR1/2, but not TLR2/6 and TLR4 results 
in significant leukocyte infiltration to the CSF and periventricular regions of the 
brain. Previously, we reported that TLR3 activation does not cause the same effect 
in leukocyte trafficking (Stridh et al., 2013). What is special about activation of 
TLR1/2? Both TLR2 and TLR4 signal through adapter molecule MyD88 leading 
to activation and translocation of transcription factor NF-κB leading to the expres-
sion of different inflammatory cytokines. TLR4, in addition, signals through an-
other adapter molecule, TRIF, leading to activation of interferon-regulating 
factors (IRFs). IRFs are transcription factors that when activated result in an in-
duction of interferon responses. We showed that LPS caused higher or similar 
level of systemic inflammation as P3C. However, the neuroinflammatory profile 
was strikingly different. One potential mechanism underlying this difference 
might be the differential expression of TLRs on immune cells and at the brain 
interface. TLR2 and TLR4, but not TLR3, are expressed in neutrophils and mon-
ocytes of neonatal and adult human and mice (Levy, 2007; Melvan et al., 2010; 
Dasari et al., 2011; Kollmann et al., 2012; Thomas and Schroder, 2013). In adult 
human monocytes the expression of TLR2 is higher than TLR4 (Hornung et al., 
2002). TLR2-4 mRNA are also expressed on brain endothelial cells as well as in 
the choroid plexus (Nagyőszi et al., 2010; Mallard, 2012; Stridh et al., 2013). 
Therefore, it is not likely that different expression patterns of TLRs underlie the 
different neuroinflammatory effects. A TLR2 specific molecular mechanism must 
be behind its special effect on leukocyte transmigration. There are some studies 
comparing the gene expression and metabolic profiles induced by TLR4 versus 
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TLR2 agonists in leukocyte subtypes (Blankley et al., 2014; Lachmandas et al., 
2016). The principal difference observed in the transcriptomic studies was that 
both TLR2 and TLR4 induce NF-κB-related genes but only TLR4 activation leads 
to expression of interferon-related genes as expected. Lachmandas et al recently 
reported that TLR2 and TLR4 stimulation induce different metabolic programs in 
human monocytes (Lachmandas et al., 2016). However, when the comparison was 
made between dosages of agonists which induced a similar level of inflammatory 
response, no significant difference was observed in the metabolic programs. 
Therefore, it is crucial to consider the dose-dependent nature of responses to dif-
ferent TLRs. Hence, in the RNA seq study (Paper IV) we used dosages of LPS 
and P3C that induce comparable inflammatory responses in the circulation. To our 
knowledge, no other studies have compared the effect of different TLR agonists 
on the brain interfaces at whole transcriptome level. However, recently, a qPCR-
based study showed that lipoteichoic acid, a TLR2 agonist, downregulated mRNA 
expression of tight junction gene claudin 5 while LPS upregulated it (Mayerhofer 
et al., 2017). Moreover, the study showed that both agonists downregulated oc-
cludin which is in agreement with our transcriptomic results.  
We demonstrated that P3C induces a specific cytokine profile in the choroid 
plexus although expression of many cytokines was similar between the two ago-
nists. Moreover, a cytoskeleton-related pathway was also induced specifically by 
P3C. Therefore, P3C induces changes at the choroid plexus that potentially are 
required for the recruitment of leukocytes and facilitation of transmigration.  
Reactive oxygen species influence many functions in cells including inflammatory 
responses (Mittal et al., 2014) and cytoskeleton/tight junctions rearrangement 
(Schreibelt et al., 2007). We showed that targeting ROS with NAC inhibited P3C-
induced leukocyte migration through choroid plexus, which was independent of 
the peripheral and central cytokine response. Therefore, the results suggest that 
ROS activity within the migrating cells or epithelial cells at the choroid plexus is 
required for TLR2-mediated cell trafficking. Altogether, the results provide evi-
dence for specific molecular mechanisms downstream of TLR2 such as chemo-
taxis and cytoskeleton pathways that might be involved in leukocyte trafficking to 
the brain. 
2- Why does TLR2 activation results in leukocyte migration 
to the CNS? 
Not all bacterial infections in the periphery leads to a massive leukocyte migration 
into the CNS. In fact, the effect of P3C in inducing leukocyte infiltration to the 
CSF best resembles clinical bacterial meningitis. P3C is a synthetic mimic of lip-
oproteins that are present in the bacterial cell wall of both gram-positive and gram-
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negative bacteria. Localization and surface projection of these lipoproteins and 
therefore their associated TLR2 activation is strain-dependent (Kovacs-Simon et 
al., 2011). Moreover, it was recently demonstrated that bacteria-induced activation 
of TLR2 is dependent on the shedding of lipoproteins from the bacterial cell wall 
(Hanzelmann et al., 2016). However, many bacterial strains that activate TLR2 do 
not cause leukocyte infiltration to the CSF. This difference in response might be 
due to the diversity of lipoprotein structure (Kovacs-Simon et al., 2011; Nakayama 
et al., 2012) in different bacterial strains and whether they bind TLR1/2 or TLR2/6 
at the brain interfaces, especially at the choroid plexus. Interestingly, some bacte-
rial strains can hijack the TLR2 signaling pathway in order to alter the epithelial 
barrier function and access the target tissue (Chun and Prince, 2009; Clarke et al., 
2011). Therefore, there might be an evolutionary competition between the im-
mune system and pathogenic bacteria related to the function of TLR2.  
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Conclusion and future 
perspective 
In this thesis, I investigated the effect of systemic inflammation on the developing 
brain in the context of HI injury (Fig. 14)  
We showed for the first time that systemic inflammation induced by intraperito-
neal injection of agonists for TLR3 (PolyI:C) and TLR2 (P3C) sensitize the neo-
natal mouse brain to subsequent HI injury. TLR3 activation augmented pro-
apoptotic and suppressed pro-survival pathways. TLR2 activation, on the other 
hand, suppressed mitochondrial respiration in the brain. Both agonists induced a 
phenotypic switch in microglia cells that might compromise their reparative func-
tion. We also demonstrated that P3C induces a substantial infiltration of leuko-
cytes to the CNS of neonatal mice and rats. Several in vivo and in vitro 
experiments suggested choroid plexus as the route of the leukocyte entry.  By 
transcriptome analysis of choroid plexus, we demonstrate potential mechanism 
underlying the P3C-induced leukocyte trafficking including a chemotaxis signa-
ture and cytoskeleton reorganization.  
Figure 14. Schematic figure summarizing the mechanism of TLR3- (left) and TLR2-induced 
(right) sensitization of developing brain to HI injury.  
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Finally, we demonstrated that the antioxidant compound, NAC, inhibits the leu-
kocyte infiltration without substantially affecting the cytokine/chemokine re-
sponse. Infection and inflammation are major risks factors for neonatal HI injury, 
and this study reveals some mechanisms underlying this association and proposes 
novel drug targets.  
In treatment of pregnancy complication such as perinatal viral infections and as-
phyxia, TLR3 might be a potential drug target to attenuate neonatal brain injury. 
Currently, no TLR3 inhibitor is clinically in use. However, some small-molecule 
probes have been described with antagonistic effect on TLR3 (Cheng et al., 2011). 
Moreover, this thesis and a previous study (Stridh et al., 2011) suggest TLR2 as a 
potential drug target, and some progress has been made in recent years in devel-
oping an inhibitor of TLR2 (Mistry et al., 2015; Patra and Choi, 2016). Therefore, 
the next step in translating our results into a therapy is to test the efficacy of these 
TLR inhibitors in pre-clinical neonatal models of HI brain injury. Moreover, we 
showed that NAC blocks the TLR2-mediated leukocyte invasion of the CNS. 
However, whether NAC diminishes the TLR2-sensitized HI injury remains to be 
investigated. We previously reported that NAC reduced the brain injury in an 
LPS+HI model in neonatal mouse, supporting its potential use in inflammation-
sensitized brain injury (Wang et al., 2007). Fortunately, the pharmacokinetics of 
NAC in mothers with chorioamnionitis has been described and its safety has been 
confirmed in two pilot trials that paves the way for further clinical investigations 
(Wiest et al., 2014; Jenkins et al., 2016). We also demonstrated that the choroid 
plexus communicates the peripheral inflammation to the brain. Whether inhibiting 
this communication alleviates the brain injury is a question that needs to be ad-
dressed in future experimental studies. Hence, in the future, choroid plexus-tar-
geted therapy might be considered as a strategy in treatment of inflammation-
sensitized brain injuries.      
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